Kv7.1
2168 literature references associated to Kv7.1
1
Lang CN
et al.
Transgenic rabbit models to investigate the cardiac ion channel disease long QT syndrome.
Prog. Biophys. Mol. Biol.,
2016
May
19
, ().
2
Lan X
et al.
Grafting voltage and pharmacological sensitivity in potassium channels.
Cell Res.,
2016
May
13
, ().
3
Ali A
et al.
Heat shock protein 70 gene polymorphisms' influence on the electrophysiology of long QT syndrome.
J Interv Card Electrophysiol,
2016
Mar
, 45 (119-30).
4
Jiang M
et al.
JPH-2 interacts with Cai-handling proteins and ion channels in dyads: Contribution to premature ventricular contraction-induced cardiomyopathy.
Heart Rhythm,
2016
Mar
, 13 (743-752).
5
Carbonell-Pascual B
et al.
Comparison between Hodgkin-Huxley and Markov formulations of cardiac ion channels.
J. Theor. Biol.,
2016
Jun
21
, 399 (92-102).
6
Yamaguchi Y
et al.
Latent pathogenicity of the G38S polymorphism of KCNE1 K(+) channel modulator.
Heart Vessels,
2016
Jun
2
, ().
7
Izumi G
et al.
Compound Mutations Cause Increased Cardiac Events in Children with Long QT Syndrome: Can the Sequence Homology-Based Tools be Applied for Prediction of Phenotypic Severity?
Pediatr Cardiol,
2016
Jun
, 37 (962-70).
8
Wu W
et al.
Molecular Basis of Cardiac Delayed Rectifier Potassium Channel Function and Pharmacology.
Card Electrophysiol Clin,
2016
Jun
, 8 (275-84).
9
Major P
et al.
A novel transgenic rabbit model with reduced repolarization reserve: long QT syndrome caused by a dominant-negative mutation of the KCNE1 gene.
Br. J. Pharmacol.,
2016
Jun
, 173 (2046-61).
10
Roy PM
et al.
Anaesthesia management of a case of Jervell and Lange-Nielsen syndrome for minimally invasive bilateral thoracoscopic cervicothoracic sympathectomy.
Indian J Anaesth,
2016
Jun
, 60 (424-6).
11
Shao H
et al.
[Relationship between electrocardiographic and genetic mutation (MYH7-H1717Q, MYLK2-K324E and KCNQ1-R190W) phenotype in patients with hypertrophic cardiomyopathy].
Zhonghua Xin Xue Guan Bing Za Zhi,
2016
Jan
24
, 44 (50-4).
12
Bodi I
et al.
Mechanisms of acquired long-QT syndrome in patients with propionic acidemia.
Heart Rhythm,
2016
Feb
5
, ().
13
Al-Hazza A
et al.
Upregulation of basolateral small conductance potassium channels (KCNQ1/KCNE3) in ulcerative colitis.
Biochem. Biophys. Res. Commun.,
2016
Feb
5
, 470 (473-8).
14
Neubauer J
et al.
Post-mortem whole-exome sequencing (WES) with a focus on cardiac disease-associated genes in five young sudden unexplained death (SUD) cases.
Int. J. Legal Med.,
2016
Feb
4
, ().
15
Fang P
et al.
[Progress in research on defective protein trafficking and functional restoration in HERG-associated long QT syndrome].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi,
2016
Feb
, 33 (101-4).
16
Rannals MD
et al.
Psychiatric Risk Gene Transcription Factor 4 Regulates Intrinsic Excitability of Prefrontal Neurons via Repression of SCN10a and KCNQ1.
Neuron,
2016
Apr
6
, 90 (43-55).
17
Crumb WJ
et al.
An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel.
J Pharmacol Toxicol Methods,
2016
Apr
6
, ().
18
Choi JI
et al.
α1-Syntrophin Variant Identified in Drug-Induced Long QT Syndrome Increases Late Sodium Current.
PLoS ONE,
2016
, 11 (e0152355).
19
Cubeddu LX
Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias.
Curr Cardiol Rev,
2016
, 12 (141-54).
20
Murray CI
et al.
Unnatural amino acid photo-crosslinking of the IKs channel complex demonstrates a KCNE1:KCNQ1 stoichiometry of up to 4:4.
Elife,
2016
, 5 ().
21
Ichikawa M
et al.
Multigenerational Inheritance of Long QT Syndrome Type 2 in a Japanese Family.
Intern. Med.,
2016
, 55 (259-62).
22
Zhao Y
et al.
Regulation of SCN3B/scn3b by Interleukin 2 (IL-2): IL-2 modulates SCN3B/scn3b transcript expression and increases sodium current in myocardial cells.
BMC Cardiovasc Disord,
2016
, 16 (1).
23
Ware WA
et al.
Sudden death associated with QT interval prolongation and KCNQ1 gene mutation in a family of English Springer Spaniels.
J. Vet. Intern. Med.,
2015 Mar-Apr
, 29 (561-8).
24
Neverisky DL
et al.
Ion channel-transporter interactions.
Crit. Rev. Biochem. Mol. Biol.,
2015 Jul-Aug
, 51 (257-67).
25
Neethling A
et al.
Filamin C: a novel component of the KCNE2 interactome during hypoxia.
Cardiovasc J Afr,
2015 Jan-Feb
, 27 (4-11).
26
Hertz CL
et al.
Genetic investigations of sudden unexpected deaths in infancy using next-generation sequencing of 100 genes associated with cardiac diseases.
Eur. J. Hum. Genet.,
2015
Sep
9
, ().
27
Coll M
et al.
Genetic investigation of sudden unexpected death in epilepsy cohort by panel target resequencing.
Int. J. Legal Med.,
2015
Sep
30
, ().
28
Abbott GW
KCNE1 and KCNE3: The yin and yang of voltage-gated K(+) channel regulation.
Gene,
2015
Sep
26
, ().
29
El-Sherif N
et al.
Role of pharmacotherapy in cardiac ion channelopathies.
Pharmacol. Ther.,
2015
Sep
12
, ().
30
Provence A
et al.
The Novel KV7.2/KV7.3 Channel Opener ICA-069673 Reveals Subtype-Specific Functional Roles in Guinea Pig Detrusor Smooth Muscle Excitability and Contractility.
J. Pharmacol. Exp. Ther.,
2015
Sep
, 354 (290-301).
31
Hu Y
et al.
Engineering a peptide inhibitor towards the KCNQ1/KCNE1 potassium channel (IKs).
Peptides,
2015
Sep
, 71 (77-83).
32
Sahu ID
et al.
Probing Structural Dynamics and Topology of the KCNE1 Membrane Protein in Lipid Bilayers via Site-Directed Spin Labeling and Electron Paramagnetic Resonance Spectroscopy.
Biochemistry,
2015
Oct
20
, 54 (6402-12).
33
Frea S
et al.
New echocardiographic insights in short QT syndrome: More than a channelopathy?
Heart Rhythm,
2015
Oct
, 12 (2096-105).
34
Andersen MN
et al.
Protein kinase A stimulates Kv7.1 surface expression by regulating Nedd4-2-dependent endocytic trafficking.
Am. J. Physiol., Cell Physiol.,
2015
Nov
15
, 309 (C693-706).
35
Kang Y
et al.
Regulation of the human ether-a-go-go-related gene (hERG) potassium channel by Nedd4 family interacting proteins (Ndfips).
Biochem. J.,
2015
Nov
15
, 472 (71-82).
36
Bakker B
et al.
A Girl With Beckwith-Wiedemann Syndrome and Pseudohypoparathyroidism Type 1B Due to Multiple Imprinting Defects.
J. Clin. Endocrinol. Metab.,
2015
Nov
, 100 (3963-6).
37
Zoledziewska M
et al.
Height-reducing variants and selection for short stature in Sardinia.
Nat. Genet.,
2015
Nov
, 47 (1352-6).
38
Powell KL
et al.
In response: LQT, HCN, and epilepsy model.
Epilepsia,
2015
Nov
, 56 (1855-6).
40
Vassilakopoulou V
et al.
Distinctive malfunctions of calmodulin mutations associated with heart RyR2-mediated arrhythmic disease.
Biochim. Biophys. Acta,
2015
Nov
, 1850 (2168-76).
41
Liin SI
et al.
Polyunsaturated fatty acid analogs act antiarrhythmically on the cardiac IKs channel.
Proc. Natl. Acad. Sci. U.S.A.,
2015
May
5
, 112 (5714-9).
42
Qian Y
et al.
Joint effect of CENTD2 and KCNQ1 polymorphisms on the risk of type 2 diabetes mellitus among Chinese Han population.
Mol. Cell. Endocrinol.,
2015
May
15
, 407 (46-51).
43
Matus M
et al.
Upregulation of SERCA2a following short-term ACE inhibition (by enalaprilat) alters contractile performance and arrhythmogenicity of healthy myocardium in rat.
Mol. Cell. Biochem.,
2015
May
, 403 (199-208).
44
Leren IS
et al.
Cardiac Mechanical Alterations and Genotype Specific Differences in Subjects With Long QT Syndrome.
JACC Cardiovasc Imaging,
2015
May
, 8 (501-10).
45
Jahangir A
et al.
Strain Echocardiography and LQTS Subtypes: Mechanical Alterations in an Electrical Disorder.
JACC Cardiovasc Imaging,
2015
May
, 8 (511-3).
46
Kolder IC
et al.
Analysis for Genetic Modifiers of Disease Severity in Patients with Long QT Syndrome Type 2.
Circ Cardiovasc Genet,
2015
Mar
3
, ().
47
Perry MD
et al.
Getting to the heart of hERG K(+) channel gating.
J. Physiol. (Lond.),
2015
Mar
27
, ().
48
Goodchild SJ
et al.
Sequence of gating charge movement and pore gating in HERG activation and deactivation pathways.
Biophys. J.,
2015
Mar
24
, 108 (1435-47).
49
Biliczki P
et al.
The interaction between delayed rectifier channel alpha-subunits does not involve hetero-tetramer formation.
Naunyn Schmiedebergs Arch. Pharmacol.,
2015
Mar
20
, ().
50
Steffensen AB
et al.
IKs Gain- and Loss-of-Function In Early-Onset Lone Atrial Fibrillation.
J. Cardiovasc. Electrophysiol.,
2015
Mar
19
, ().
51
Villoutreix BO
et al.
Computational investigations of hERG channel blockers: New insights and current predictive models.
Adv. Drug Deliv. Rev.,
2015
Mar
12
, ().
52
Laurentino S
et al.
Epigenetic germline mosaicism in infertile men.
Hum. Mol. Genet.,
2015
Mar
1
, 24 (1295-304).
53
Gómez-Úriz AM
et al.
Obesity and ischemic stroke modulate the methylation levels of KCNQ1 in white blood cells.
Hum. Mol. Genet.,
2015
Mar
1
, 24 (1432-40).
54
Wang W
et al.
Identification of a key residue in Kv7.1 potassium channel essential for sensing external potassium ions.
J. Gen. Physiol.,
2015
Mar
, 145 (201-12).
55
Hiippala A
et al.
Expanding the phenotype of Timothy syndrome type 2: an adolescent with ventricular fibrillation but normal development.
Am. J. Med. Genet. A,
2015
Mar
, 167A (629-34).
56
Huang J
et al.
Genetic variants in KCNE1, KCNQ1, and NOS1AP in sudden unexplained death during daily activities in Chinese Han population.
J. Forensic Sci.,
2015
Mar
, 60 (351-6).
57
Wemhöner K
et al.
Gain-of-function mutations in the calcium channel CACNA1C (Cav1.2) cause non-syndromic long-QT but not Timothy syndrome.
J. Mol. Cell. Cardiol.,
2015
Mar
, 80 (186-95).
58
Stott JB
et al.
Contribution of kv7 channels to natriuretic Peptide mediated vasodilation in normal and hypertensive rats.
Hypertension,
2015
Mar
, 65 (676-82).
59
Yang L
et al.
Intravenous anesthetic propofol inhibits multiple human cardiac potassium channels.
Anesthesiology,
2015
Mar
, 122 (571-84).
60
Hayashi K
et al.
Functional Characterization of Rare Variants Implicated in Susceptibility to Lone Atrial Fibrillation.
Circ Arrhythm Electrophysiol,
2015
Jun
30
, ().
61
Liin SI
et al.
The KCNQ1 channel - remarkable flexibility in gating allows for functional versatility.
J. Physiol. (Lond.),
2015
Jun
15
, 593 (2605-15).
62
Fu Y
et al.
Association between maternal single nucleotide polymorphisms in genes regulating glucose metabolism and risk for neural tube defects in offspring.
Birth Defects Res. Part A Clin. Mol. Teratol.,
2015
Jun
, 103 (471-8).
63
Mills TA
et al.
Activation of KV7 channels stimulates vasodilatation of human placental chorionic plate arteries.
Placenta,
2015
Jun
, 36 (638-44).
64
Kouvaros S
et al.
Hippocampal sharp waves and ripples: Effects of aging and modulation by NMDA receptors and L-type Ca2+ channels.
Neuroscience,
2015
Jul
9
, 298 (26-41).
65
Asahara S
et al.
Paternal allelic mutation at the Kcnq1 locus reduces pancreatic β-cell mass by epigenetic modification of Cdkn1c.
Proc. Natl. Acad. Sci. U.S.A.,
2015
Jul
7
, 112 (8332-7).
66
Stattin EL
et al.
Genetic screening in sudden cardiac death in the young can save future lives.
Int. J. Legal Med.,
2015
Jul
31
, ().
67
Harrell DT
et al.
Genotype-dependent differences in age of manifestation and arrhythmia complications in short QT syndrome.
Int. J. Cardiol.,
2015
Jul
1
, 190 (393-402).
68
Wu ZJ
et al.
Characterization of a Chinese KCNQ1 mutation (R259H) that shortens repolarization and causes short QT syndrome 2.
J Geriatr Cardiol,
2015
Jul
, 12 (394-401).
69
Kienitz MC
et al.
Synergistic modulation of KCNQ1/KCNE1 K(+) channels (IKs) by phosphatidylinositol 4,5-bisphosphate (PIP2) and [ATP]i.
Cell. Signal.,
2015
Jul
, 27 (1457-68).
70
Issa NP
et al.
QT interval prolongation in a patient with LQT2 on levetiracetam.
Seizure,
2015
Jul
, 29 (134-6).
71
72
Hiramoto M
et al.
Comparative analysis of type 2 diabetes-associated SNP alleles identifies allele-specific DNA-binding proteins for the KCNQ1 locus.
Int. J. Mol. Med.,
2015
Jul
, 36 (222-30).
73
Yoshizawa S
et al.
Pyrrole-imidazole polyamide-mediated silencing of KCNQ1OT1 expression induces cell death in Wilms' tumor cells.
Int. J. Oncol.,
2015
Jul
, 47 (115-21).
74
Li L
et al.
Genetic variants of potassium voltage-gated channel genes (KCNQ1, KCNH2, and KCNE1) affected the risk of atrial fibrillation in elderly patients.
Genet Test Mol Biomarkers,
2015
Jul
, 19 (359-65).
75
Vucic E
et al.
Kir1.1 (ROMK) and Kv7.1 (KCNQ1/KvLQT1) are essential for normal gastric acid secretion: importance of functional Kir1.1.
Pflugers Arch.,
2015
Jul
, 467 (1457-68).
76
Xu Y
et al.
Probing binding sites and mechanisms of action of an I(Ks) activator by computations and experiments.
Biophys. J.,
2015
Jan
6
, 108 (62-75).
77
Zhang J
et al.
Electrophysiological and trafficking defects of the SCN5A T353I mutation in Brugada syndrome are rescued by alpha-allocryptopine.
Eur. J. Pharmacol.,
2015
Jan
5
, 746 (333-43).
78
Chong E
et al.
Resveratrol, a red wine antioxidant, reduces atrial fibrillation susceptibility in the failing heart by PI3K/AKT/eNOS signaling pathway activation.
Heart Rhythm,
2015
Jan
30
, ().
79
Nakajo K
et al.
KCNQ1 channel modulation by KCNE proteins via the voltage-sensing domain.
J. Physiol. (Lond.),
2015
Jan
21
, ().
80
Gayen S
et al.
Structural analysis of the S4-S5 linker of the human KCNQ1 potassium channel.
Biochem. Biophys. Res. Commun.,
2015
Jan
2
, 456 (410-4).
81
ter Bekke RM
et al.
Electromechanical window negativity in genotyped long-QT syndrome patients: relation to arrhythmia risk.
Eur. Heart J.,
2015
Jan
14
, 36 (179-86).
82
Sedivy V
et al.
Role of Kv7 channels in responses of the pulmonary circulation to hypoxia.
Am. J. Physiol. Lung Cell Mol. Physiol.,
2015
Jan
1
, 308 (L48-57).
83
Costello JP
et al.
Surgical cardiac denervation therapy for treatment of congenital ion channelopathies in pediatric patients: a contemporary, single institutional experience.
World J Pediatr Congenit Heart Surg,
2015
Jan
, 6 (33-8).
84
Xiong Q
et al.
Arrhythmogenic cardiomyopathy in a patient with a rare loss-of-function KCNQ1 mutation.
J Am Heart Assoc,
2015
Jan
, 4 (e001526).
86
Riuró H
et al.
Genetic analysis, in silico prediction, and family segregation in long QT syndrome.
Eur. J. Hum. Genet.,
2015
Jan
, 23 (79-85).
87
Kim TY
et al.
Complex excitation dynamics underlie polymorphic ventricular tachycardia in a transgenic rabbit model of long QT syndrome type 1.
Heart Rhythm,
2015
Jan
, 12 (220-8).
88
Schultz BM
et al.
Enhancers compete with a long non-coding RNA for regulation of the Kcnq1 domain.
Nucleic Acids Res.,
2015
Jan
, 43 (745-59).
89
Porta A
et al.
Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1.
J. Am. Coll. Cardiol.,
2015
Feb
3
, 65 (367-74).
90
Moreno C
et al.
Marine n-3 PUFAs modulate IKs gating, channel expression, and location in membrane microdomains.
Cardiovasc. Res.,
2015
Feb
1
, 105 (223-32).
91
O-Uchi J
et al.
Impaired IKs channel activation by Ca(2+)-dependent PKC shows correlation with emotion/arousal-triggered events in LQT1.
J. Mol. Cell. Cardiol.,
2015
Feb
, 79 (203-11).
92
Tseng GN
et al.
Understanding the microscopic mechanisms for LQT1 needs a global view of the I(Ks) channel.
Heart Rhythm,
2015
Feb
, 12 (395-6).
93
Eldstrom J
et al.
Microscopic mechanisms for long QT syndrome type 1 revealed by single-channel analysis of I(Ks) with S3 domain mutations in KCNQ1.
Heart Rhythm,
2015
Feb
, 12 (386-94).
94
de Llano CT
et al.
Further evidence of the association between LQT syndrome and epilepsy in a family with KCNQ1 pathogenic variant.
Seizure,
2015
Feb
, 25 (65-7).
95
Lee S
et al.
Heterogeneity in Kv7 channel function in the cerebral and coronary circulation.
Microcirculation,
2015
Feb
, 22 (109-21).
96
Winbo A
et al.
Vestibular dysfunction is a clinical feature of the Jervell and Lange-Nielsen Syndrome.
Scand. Cardiovasc. J.,
2015
Feb
, 49 (7-13).
97
Anderson HN
et al.
Marked, transient, emotion-triggered QT accentuation in an adolescent female with type 1 long QT syndrome.
Cardiol Young,
2015
Feb
, 25 (376-9).
98
Nekouzadeh A
et al.
Conformational changes of an ion-channel during gating and emerging electrophysiologic properties: Application of a computational approach to cardiac Kv7.1.
Prog. Biophys. Mol. Biol.,
2015
Dec
30
, ().
99
Zhu W
et al.
Molecular motions that shape the cardiac action potential: Insights from voltage clamp fluorometry.
Prog. Biophys. Mol. Biol.,
2015
Dec
25
, ().
100
Peters CH
et al.
Triggers for arrhythmogenesis in the Brugada and long QT 3 syndromes.
Prog. Biophys. Mol. Biol.,
2015
Dec
20
, ().
101
Slaats GG
et al.
Screen-based identification and validation of four new ion channels as regulators of renal ciliogenesis.
J. Cell. Sci.,
2015
Dec
15
, 128 (4550-9).
102
Robyns T
et al.
Targeted capture sequencing in a large LQTS family reveals a new pathogenic mutation c.2038delG in KCNH2 initially missed due to allelic dropout.
Acta Cardiol,
2015
Dec
, 70 (747-9).
103
Qureshi SF
et al.
Mutational analysis of SCN5A gene in long QT syndrome.
Meta Gene,
2015
Dec
, 6 (26-35).
104
Kanters JK
et al.
Combined gating and trafficking defect in Kv11.1 manifests as a malignant long QT syndrome phenotype in a large Danish p.F29L founder family.
Scand. J. Clin. Lab. Invest.,
2015
Dec
, 75 (699-709).
105
Wasano K
et al.
A novel frameshift mutation in KCNQ4 in a family with autosomal recessive non-syndromic hearing loss.
Biochem. Biophys. Res. Commun.,
2015
Aug
7
, 463 (582-6).
106
Zhi D
et al.
The enhancement of cardiac toxicity by concomitant administration of Berberine and macrolides.
Eur J Pharm Sci,
2015
Aug
30
, 76 (149-55).
107
Yuan J
et al.
Potassium channel KCNJ15 is required for histamine-stimulated gastric acid secretion.
Am. J. Physiol., Cell Physiol.,
2015
Aug
15
, 309 (C264-70).
108
Anneken L
et al.
Estradiol regulates human QT-interval: acceleration of cardiac repolarization by enhanced KCNH2 membrane trafficking.
Eur. Heart J.,
2015
Aug
12
, ().
109
Koponen M
et al.
Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects.
Circ Arrhythm Electrophysiol,
2015
Aug
, 8 (815-23).
110
Krönauer T
et al.
[Perioperative treatment of patients with long QT syndrome].
Anaesthesist,
2015
Aug
, 64 (625-39).
111
Imam MH
et al.
A novel technique to investigate the effect of ageing on ventricular repolarization characteristics in healthy and LQTS subjects.
Conf Proc IEEE Eng Med Biol Soc,
2015
Aug
, 2015 (2796-9).
112
Li G
et al.
RNA interference-based therapeutics for inherited long QT syndrome.
Exp Ther Med,
2015
Aug
, 10 (395-400).
113
Krönauer T
et al.
[Long QT syndrome : History, genetics, clinical symptoms, causes and therapy].
Anaesthesist,
2015
Aug
, 64 (586-95).
114
Winbo A
et al.
Third trimester fetal heart rate predicts phenotype and mutation burden in the type 1 long QT syndrome.
Circ Arrhythm Electrophysiol,
2015
Aug
, 8 (806-14).
115
Potet F
et al.
Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels.
Circ Arrhythm Electrophysiol,
2015
Aug
, 8 (933-41).
116
Chang Q
et al.
Virally mediated Kcnq1 gene replacement therapy in the immature scala media restores hearing in a mouse model of human Jervell and Lange-Nielsen deafness syndrome.
EMBO Mol Med,
2015
Aug
, 7 (1077-86).
117
Lampert R
Reassuring News for Genetically Tested, Appropriately Treated, Low-Risk LQTS Patients.
J. Cardiovasc. Electrophysiol.,
2015
Aug
, 26 (859-61).
118
Chen J
et al.
SjAPI-2 is the first member of a new neurotoxin family with Ascaris-type fold and KCNQ1 inhibitory activity.
Int. J. Biol. Macromol.,
2015
Aug
, 79 (504-10).
119
Osterbur ML
et al.
An Interdomain KCNH2 Mutation Produces an Intermediate Long QT Syndrome.
Hum. Mutat.,
2015
Aug
, 36 (764-73).
120
Zhang C
et al.
Identification of Low-Risk Adult Congenital LQTS Patients.
J. Cardiovasc. Electrophysiol.,
2015
Aug
, 26 (853-8).
121
Christ T
et al.
LQT1-phenotypes in hiPSC: Are we measuring the right thing?
Proc. Natl. Acad. Sci. U.S.A.,
2015
Apr
21
, 112 (E1968).
122
Greber B
et al.
Reply to Christ et al.: LQT1 and JLNS phenotypes in hiPSC-derived cardiomyocytes are due to KCNQ1 mutations.
Proc. Natl. Acad. Sci. U.S.A.,
2015
Apr
21
, 112 (E1969).
123
Morales-Cano D
et al.
Kv7 channels critically determine coronary artery reactivity: left-right differences and down-regulation by hyperglycaemia.
Cardiovasc. Res.,
2015
Apr
1
, 106 (98-108).
124
Kapplinger JD
et al.
Enhancing the Predictive Power of Mutations in the C-Terminus of the KCNQ1-Encoded Kv7.1 Voltage-Gated Potassium Channel.
J Cardiovasc Transl Res,
2015
Apr
, 8 (187-97).
125
Williams VS
et al.
Multiplex ligation-dependent probe amplification copy number variant analysis in patients with acquired long QT syndrome.
Europace,
2015
Apr
, 17 (635-41).
126
Lau E
et al.
Spatially Discordant Alternans and Arrhythmias in Tachypacing-Induced Cardiac Myopathy in Transgenic LQT1 Rabbits: The Importance of IKs and Ca2+ Cycling.
PLoS ONE,
2015
, 10 (e0122754).
127
Kasimova MA
et al.
PIP₂-dependent coupling is prominent in Kv7.1 due to weakened interactions between S4-S5 and S6.
Sci Rep,
2015
, 5 (7474).
128
Kong X
et al.
The Association of Type 2 Diabetes Loci Identified in Genome-Wide Association Studies with Metabolic Syndrome and Its Components in a Chinese Population with Type 2 Diabetes.
PLoS ONE,
2015
, 10 (e0143607).
129
Pedersen PJ
et al.
Molecular Cloning and Functional Expression of the Equine K+ Channel KV11.1 (Ether à Go-Go-Related/KCNH2 Gene) and the Regulatory Subunit KCNE2 from Equine Myocardium.
PLoS ONE,
2015
, 10 (e0138320).
130
Ao D
et al.
The rs2237892 Polymorphism in KCNQ1 Influences Gestational Diabetes Mellitus and Glucose Levels: A Case-Control Study and Meta-Analysis.
PLoS ONE,
2015
, 10 (e0128901).
131
Mayo S
et al.
In Pursuit of New Imprinting Syndromes by Epimutation Screening in Idiopathic Neurodevelopmental Disorder Patients.
Biomed Res Int,
2015
, 2015 (341986).
132
Liu X
et al.
Effects of IGF2BP2, KCNQ1 and GCKR polymorphisms on clinical outcome in metastatic gastric cancer treated with EOF regimen.
Pharmacogenomics,
2015
, 16 (959-70).
133
Itoh H
et al.
A Common Mutation of Long QT Syndrome Type 1 in Japan.
Circ. J.,
2015
, 79 (2026-30).
134
Inanobe A
et al.
An Epithelial Ca2+-Sensor Protein is an Alternative to Calmodulin to Compose Functional KCNQ1 Channels.
Cell. Physiol. Biochem.,
2015
, 36 (1847-61).
135
Allegue C
et al.
Genetic Analysis of Arrhythmogenic Diseases in the Era of NGS: The Complexity of Clinical Decision-Making in Brugada Syndrome.
PLoS ONE,
2015
, 10 (e0133037).
136
Abete I
et al.
Epigenetic Changes in the Methylation Patterns of KCNQ1 and WT1 after a Weight Loss Intervention Program in Obese Stroke Patients.
Curr Neurovasc Res,
2015
, 12 (321-33).
137
Koppes E
et al.
Partial Loss of Genomic Imprinting Reveals Important Roles for Kcnq1 and Peg10 Imprinted Domains in Placental Development.
PLoS ONE,
2015
, 10 (e0135202).
138
Warsi J
et al.
Regulation of Voltage Gated K+ Channel KCNE1/KCNQ1 by the Janus Kinase JAK3.
Cell. Physiol. Biochem.,
2015
, 37 (2476-85).
139
Cazals Y
et al.
KCNK5 channels mostly expressed in cochlear outer sulcus cells are indispensable for hearing.
Nat Commun,
2015
, 6 (8780).
140
Bellin M
et al.
Human iPS cell models of Jervell and Lange-Nielsen syndrome.
Rare Dis,
2015
, 3 (e1012978).
141
Huerta-Chagoya A
et al.
Genetic determinants for gestational diabetes mellitus and related metabolic traits in Mexican women.
PLoS ONE,
2015
, 10 (e0126408).
142
Hu RM
et al.
Arrhythmogenic Biophysical Phenotype for SCN5A Mutation S1787N Depends upon Splice Variant Background and Intracellular Acidosis.
PLoS ONE,
2015
, 10 (e0124921).
143
Liu QN
et al.
Eag Domains Regulate LQT Mutant hERG Channels in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
PLoS ONE,
2015
, 10 (e0123951).
144
145
Svalø J
et al.
Functional and molecular evidence for Kv7 channel subtypes in human detrusor from patients with and without bladder outflow obstruction.
PLoS ONE,
2015
, 10 (e0117350).
146
Sun P
et al.
A distinct three-helix centipede toxin SSD609 inhibits I(ks) channels by interacting with the KCNE1 auxiliary subunit.
Sci Rep,
2015
, 5 (13399).
147
Chang YS
et al.
Mutation Analysis of KCNQ1, KCNH2 and SCN5A Genes in Taiwanese Long QT Syndrome Patients.
Int Heart J,
2015
, 56 (450-3).
148
Steffensen AB
et al.
High incidence of functional ion-channel abnormalities in a consecutive Long QT cohort with novel missense genetic variants of unknown significance.
Sci Rep,
2015
, 5 (10009).
149
Al-Aama JY
et al.
Genotype-phenotype analysis of Jervell and Lange-Nielsen syndrome in six families from Saudi Arabia.
Clin. Genet.,
2015
, 87 (74-9).
150
Leong IU
et al.
Assessment of the predictive accuracy of five in silico prediction tools, alone or in combination, and two metaservers to classify long QT syndrome gene mutations.
BMC Med. Genet.,
2015
, 16 (34).
151
Lazzerini PE
et al.
Long QT Syndrome: An Emerging Role for Inflammation and Immunity.
Front Cardiovasc Med,
2015
, 2 (26).
152
Kılıç E
et al.
Jervell and Lange-Nielsen syndrome with homozygous missense mutation of the KCNQ1 gene.
Turk. J. Pediatr.,
2014 Sep-Oct
, 56 (542-5).
153
Lazaraviciute G
et al.
A systematic review and meta-analysis of DNA methylation levels and imprinting disorders in children conceived by IVF/ICSI compared with children conceived spontaneously.
Hum. Reprod. Update,
2014 Nov-Dec
, 20 (840-52).
154
Mirams GR
et al.
Prediction of Thorough QT study results using action potential simulations based on ion channel screens.
J Pharmacol Toxicol Methods,
2014 Nov-Dec
, 70 (246-54).
155
Hancox JC
et al.
In silico investigation of a KCNQ1 mutation associated with familial atrial fibrillation.
J Electrocardiol,
2014 Mar-Apr
, 47 (158-65).
156
Dvir M
et al.
Long QT mutations at the interface between KCNQ1 helix C and KCNE1 disrupt I(KS) regulation by PKA and PIP₂.
J. Cell. Sci.,
2014
Sep
15
, 127 (3943-55).
157
Choi SH
et al.
Ginseng gintonin activates the human cardiac delayed rectifier K+ channel: involvement of Ca2+/calmodulin binding sites.
Mol. Cells,
2014
Sep
, 37 (656-63).
158
Imaniastuti R
et al.
Computational prediction of proarrhythmogenic effect of the V241F KCNQ1 mutation in human atrium.
Prog. Biophys. Mol. Biol.,
2014
Sep
, 116 (70-5).
159
Laksman ZW
et al.
Early repolarization is associated with symptoms in patients with type 1 and type 2 long QT syndrome.
Heart Rhythm,
2014
Sep
, 11 (1632-8).
160
Sung JY
et al.
Large deletion in KCNQ1 identified in a family with Jervell and Lange-Nielsen syndrome.
Ann Lab Med,
2014
Sep
, 34 (395-8).
161
van Hoeijen DA
et al.
Cardiac sodium channels and inherited electrophysiological disorders: an update on the pharmacotherapy.
Expert Opin Pharmacother,
2014
Sep
, 15 (1875-87).
162
Han SN
et al.
Identification and functional characterization of the human ether-a-go-go-related gene Q738X mutant associated with hereditary long QT syndrome type 2.
Int. J. Mol. Med.,
2014
Sep
, 34 (810-5).
163
Limpitikul WB
et al.
Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca(2+) currents and promote proarrhythmic behavior in ventricular myocytes.
J. Mol. Cell. Cardiol.,
2014
Sep
, 74 (115-24).
164
Khatami F
et al.
The mitochondrial DNA mutations associated with cardiac arrhythmia investigated in an LQTS family.
Iran J Basic Med Sci,
2014
Sep
, 17 (656-61).
165
Singhal R
et al.
Colchicine suppresses atrial fibrillation in failing heart.
Int. J. Cardiol.,
2014
Oct
20
, 176 (651-60).
166
Olde Nordkamp LR
et al.
Syncope in genotype-negative long QT syndrome family members.
Am. J. Cardiol.,
2014
Oct
15
, 114 (1223-8).
167
Wen W
et al.
Meta-analysis of genome-wide association studies in East Asian-ancestry populations identifies four new loci for body mass index.
Hum. Mol. Genet.,
2014
Oct
15
, 23 (5492-504).
168
Sahu ID
et al.
Structural investigation of the transmembrane domain of KCNE1 in proteoliposomes.
Biochemistry,
2014
Oct
14
, 53 (6392-401).
169
Spätjens RL
et al.
Long-QT mutation p.K557E-Kv7.1: dominant-negative suppression of IKs, but preserved cAMP-dependent up-regulation.
Cardiovasc. Res.,
2014
Oct
1
, 104 (216-25).
170
Cordeiro A
et al.
Relevance of genomic imprinting in intrauterine human growth expression of CDKN1C, H19, IGF2, KCNQ1 and PHLDA2 imprinted genes.
J. Assist. Reprod. Genet.,
2014
Oct
, 31 (1361-8).
171
Adler A
et al.
First report of a large duplication of the KCNQ1 gene in a patient with long QT syndrome.
Can J Cardiol,
2014
Oct
, 30 (1249.e5-7).
172
Terentyev D
et al.
Hyperphosphorylation of RyRs underlies triggered activity in transgenic rabbit model of LQT2 syndrome.
Circ. Res.,
2014
Nov
7
, 115 (919-28).
173
Anwar-Mohamed A
et al.
A human ether-á-go-go-related (hERG) ion channel atomistic model generated by long supercomputer molecular dynamics simulations and its use in predicting drug cardiotoxicity.
Toxicol. Lett.,
2014
Nov
4
, 230 (382-92).
174
Sachyani D
et al.
Structural basis of a Kv7.1 potassium channel gating module: studies of the intracellular c-terminal domain in complex with calmodulin.
Structure,
2014
Nov
4
, 22 (1582-94).
175
Li J
et al.
Induced KCNQ1 autoimmunity accelerates cardiac repolarization in rabbits: potential significance in arrhythmogenesis and antiarrhythmic therapy.
Heart Rhythm,
2014
Nov
, 11 (2092-100).
176
Al-Aama JY
et al.
De novo mutation in the KCNQ1 gene causal to Jervell and Lange-Nielsen syndrome.
Clin. Genet.,
2014
Nov
, 86 (492-5).
177
Hedley PL
et al.
MicroRNAs in cardiac arrhythmia: DNA sequence variation of MiR-1 and MiR-133A in long QT syndrome.
Scand. J. Clin. Lab. Invest.,
2014
May
8
, ().
178
Frolov RV
et al.
Celecoxib and ion channels: a story of unexpected discoveries.
Eur. J. Pharmacol.,
2014
May
5
, 730 (61-71).
179
Thomas PV
et al.
Localization and proteomic characterization of cholesterol-rich membrane microdomains in the inner ear.
J Proteomics,
2014
May
30
, 103 (178-93).
180
Mistry HD
et al.
Expression of voltage-dependent potassium channels in first trimester human placentae.
Placenta,
2014
May
, 35 (337-40).
181
Grunnet M
et al.
Kv7 channels as targets for anti-epileptic and psychiatric drug-development.
Eur. J. Pharmacol.,
2014
Mar
5
, 726 (133-7).
182
Abbott GW
et al.
KCNQ1, KCNE2, and Na+-coupled solute transporters form reciprocally regulating complexes that affect neuronal excitability.
Sci Signal,
2014
Mar
4
, 7 (ra22).
183
Wu J
et al.
A molecular mechanism for adrenergic-induced long QT syndrome.
J. Am. Coll. Cardiol.,
2014
Mar
4
, 63 (819-27).
184
Schwartz PJ
et al.
Sudden death by stress: how far under the nerves should we dig to find out why LQT1 patients die?
J. Am. Coll. Cardiol.,
2014
Mar
4
, 63 (828-30).
185
Hwang HS
et al.
Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutants.
Circ. Res.,
2014
Mar
28
, 114 (1114-24).
186
Brueggemann LI
et al.
KCNQ (Kv7) potassium channel activators as bronchodilators: combination with a β2-adrenergic agonist enhances relaxation of rat airways.
Am. J. Physiol. Lung Cell Mol. Physiol.,
2014
Mar
15
, 306 (L476-86).
187
Aflaki M
et al.
Exchange protein directly activated by cAMP mediates slow delayed-rectifier current remodeling by sustained β-adrenergic activation in guinea pig hearts.
Circ. Res.,
2014
Mar
14
, 114 (993-1003).
188
Shimizu W
[Current status and future perspective in inherited cardiac arrhythmias].
Nippon Rinsho,
2014
Mar
, 72 (553-63).
189
Chang RK
et al.
Genetic variants for long QT syndrome among infants and children from a statewide newborn hearing screening program cohort.
J. Pediatr.,
2014
Mar
, 164 (590-5.e1-3).
190
Girault A
et al.
Identification of KvLQT1 K+ channels as new regulators of non-small cell lung cancer cell proliferation and migration.
Int. J. Oncol.,
2014
Mar
, 44 (838-48).
191
Ki CS
et al.
A KCNQ1 mutation causes age-dependant bradycardia and persistent atrial fibrillation.
Pflugers Arch.,
2014
Mar
, 466 (529-40).
192
Shimizu T
et al.
Up-regulation of Kv7.1 channels in thromboxane A2-induced colonic cancer cell proliferation.
Pflugers Arch.,
2014
Mar
, 466 (541-8).
193
Bartos DC
et al.
A KCNQ1 mutation contributes to the concealed type 1 long QT phenotype by limiting the Kv7.1 channel conformational changes associated with protein kinase A phosphorylation.
Heart Rhythm,
2014
Mar
, 11 (459-68).
194
Jepps TA
et al.
Vasorelaxant effects of novel Kv7.4 channel enhancers ML213 and NS15370.
Br. J. Pharmacol.,
2014
Jun
9
, ().
195
Priest JR
et al.
Molecular Diagnosis of Long-QT syndrome at 10 Days of Life by Rapid Whole Genome Sequencing.
Heart Rhythm,
2014
Jun
25
, ().
196
Odening KE
et al.
How do Sex Hormones Modify Arrhythmogenesis in Long-QT Syndrome? - Sex Hormone Effects on Arrhythmogenic Substrate and Triggered Activity.
Heart Rhythm,
2014
Jun
19
, ().
197
Currò D
K+ channels as potential targets for the treatment of gastrointestinal motor disorders.
Eur. J. Pharmacol.,
2014
Jun
15
, 733 (97-101).
198
Mehta A
et al.
Re-trafficking of hERG reverses long QT syndrome 2 phenotype in human iPS-derived cardiomyocytes.
Cardiovasc. Res.,
2014
Jun
1
, 102 (497-506).
199
Yin G
et al.
Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms.
J Am Heart Assoc,
2014
Jun
, 3 (e000996).
200
Kinoshita K
et al.
A590T mutation in KCNQ1 C-terminal helix D decreases IKs channel trafficking and function but not Yotiao interaction.
J. Mol. Cell. Cardiol.,
2014
Jul
, 72 (273-80).
201
Glengarry JM
et al.
Long QT molecular autopsy in sudden infant death syndrome.
Arch. Dis. Child.,
2014
Jul
, 99 (635-40).
202
Romero L
et al.
In silico screening of the impact of hERG channel kinetic abnormalities on channel block and susceptibility to acquired long QT syndrome.
J. Mol. Cell. Cardiol.,
2014
Jul
, 72 (126-37).
203
Liu W
et al.
KCNE2 modulates cardiac L-type Ca(2+) channel.
J. Mol. Cell. Cardiol.,
2014
Jul
, 72 (208-18).
204
Riuró H
et al.
A missense mutation in the sodium channel β1b subunit reveals SCN1B as a susceptibility gene underlying long QT syndrome.
Heart Rhythm,
2014
Jul
, 11 (1202-9).
205
Jackson HA
et al.
LQTS in Northern BC: homozygosity for KCNQ1 V205M presents with a more severe cardiac phenotype but with minimal impact on auditory function.
Clin. Genet.,
2014
Jul
, 86 (85-90).
206
Oliveras A
et al.
Functional assembly of kv7.1/kv7.5 channels with emerging properties on vascular muscle physiology.
Arterioscler. Thromb. Vasc. Biol.,
2014
Jul
, 34 (1522-30).
207
Sakata S
et al.
Instability of KCNE1-D85N that causes long QT syndrome: stabilization by verapamil.
Pacing Clin Electrophysiol,
2014
Jul
, 37 (853-63).
208
Zhang H
et al.
Long noncoding RNA-mediated intrachromosomal interactions promote imprinting at the Kcnq1 locus.
J. Cell Biol.,
2014
Jan
6
, 204 (61-75).
209
Brueggemann LI
et al.
Differential protein kinase C-dependent modulation of Kv7.4 and Kv7.5 subunits of vascular Kv7 channels.
J. Biol. Chem.,
2014
Jan
24
, 289 (2099-111).
210
Lang F
et al.
Regulation of transport across cell membranes by the serum- and glucocorticoid-inducible kinase SGK1.
Mol. Membr. Biol.,
2014
Jan
14
, ().
211
D'Argenio V
et al.
DNA sequence capture and next-generation sequencing for the molecular diagnosis of genetic cardiomyopathies.
J Mol Diagn,
2014
Jan
, 16 (32-44).
212
Hata Y
et al.
Identification and characterization of a novel genetic mutation with prolonged QT syndrome in an unexplained postoperative death.
Int. J. Legal Med.,
2014
Jan
, 128 (105-15).
213
Mints Y
et al.
Single nucleotide polymorphisms in proximity to K-channel genes are associated with decreased longitudinal QTc variance.
Ann Noninvasive Electrocardiol,
2014
Jan
, 19 (63-9).
214
Mennerick S
et al.
Phosphatidylinositol 4,5-bisphosphate depletion fails to affect neurosteroid modulation of GABAA receptor function.
Psychopharmacology (Berl.),
2014
Feb
20
, ().
215
Li YY
et al.
KCNQ1 rs2237892 C→T gene polymorphism and type 2 diabetes mellitus in the Asian population: a meta-analysis of 15,736 patients.
J. Cell. Mol. Med.,
2014
Feb
, 18 (274-82).
216
Azzi S
et al.
Beckwith-Wiedemann and Russell-Silver Syndromes: from new molecular insights to the comprehension of imprinting regulation.
Curr Opin Endocrinol Diabetes Obes,
2014
Feb
, 21 (30-8).
217
Zhang Y
et al.
The SCN5A mutation A1180V is associated with electrocardiographic features of LQT3.
Pediatr Cardiol,
2014
Feb
, 35 (295-300).
218
Marquis-Nicholson R
et al.
Array comparative genomic hybridization identifies a heterozygous deletion of the entire KCNJ2 gene as a cause of sudden cardiac death.
Circ Cardiovasc Genet,
2014
Feb
, 7 (17-22).
219
Zhang M
et al.
Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: disease mechanisms and pharmacological rescue.
Proc. Natl. Acad. Sci. U.S.A.,
2014
Dec
16
, 111 (E5383-92).
220
Schroder EA
et al.
Light phase-restricted feeding slows basal heart rate to exaggerate the type-3 long QT syndrome phenotype in mice.
Am. J. Physiol. Heart Circ. Physiol.,
2014
Dec
15
, 307 (H1777-85).
221
Xie R
et al.
Molecular mechanisms of calcium-sensing receptor-mediated calcium signaling in the modulation of epithelial ion transport and bicarbonate secretion.
J. Biol. Chem.,
2014
Dec
12
, 289 (34642-53).
222
Aromolaran AS
et al.
LQT1 mutations in KCNQ1 C-terminus assembly domain suppress IKs using different mechanisms.
Cardiovasc. Res.,
2014
Dec
1
, 104 (501-11).
223
Fukuyama M
et al.
Long QT syndrome type 8: novel CACNA1C mutations causing QT prolongation and variant phenotypes.
Europace,
2014
Dec
, 16 (1828-37).
224
Zhang KP
et al.
Translational toxicology and rescue strategies of the hERG channel dysfunction: biochemical and molecular mechanistic aspects.
Acta Pharmacol. Sin.,
2014
Dec
, 35 (1473-84).
225
Bond R
et al.
Congenital long QT syndrome: a case report of LQT2 and LQT13 in a neonate.
Europace,
2014
Dec
, 16 (1807).
226
Li P
et al.
The human ether-a-go-go-related gene activator NS1643 enhances epilepsy-associated KCNQ channels.
J. Pharmacol. Exp. Ther.,
2014
Dec
, 351 (596-604).
227
Salsbury G
et al.
Disruption of the potassium channel regulatory subunit KCNE2 causes iron-deficient anemia.
Exp. Hematol.,
2014
Dec
, 42 (1053-8.e1).
228
Wang Y
et al.
Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing.
J. Am. Coll. Cardiol.,
2014
Aug
5
, 64 (451-9).
229
Eckey K
et al.
Novel Kv7.1-phosphatidylinositol 4,5-bisphosphate interaction sites uncovered by charge neutralization scanning.
J. Biol. Chem.,
2014
Aug
15
, 289 (22749-58).
230
Harmer SC
et al.
Cellular mechanisms underlying the increased disease severity seen for patients with long QT syndrome caused by compound mutations in KCNQ1.
Biochem. J.,
2014
Aug
15
, 462 (133-42).
231
Spencer CI
et al.
Calcium transients closely reflect prolonged action potentials in iPSC models of inherited cardiac arrhythmia.
Stem Cell Reports,
2014
Aug
12
, 3 (269-81).
232
Imai M
et al.
Novel KCNQ1 splicing mutation in patients with forme fruste LQT1 aggravated by hypokalemia.
J Cardiol,
2014
Aug
, 64 (121-6).
233
Kukla P
et al.
Electrocardiogram in Andersen-Tawil syndrome. New electrocardiographic criteria for diagnosis of type-1 Andersen-Tawil syndrome.
Curr Cardiol Rev,
2014
Aug
, 10 (222-8).
234
Demars J
et al.
Genetic variants within the second intron of the KCNQ1 gene affect CTCF binding and confer a risk of Beckwith-Wiedemann syndrome upon maternal transmission.
J. Med. Genet.,
2014
Aug
, 51 (502-11).
235
Ng MC
et al.
Meta-analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes.
PLoS Genet.,
2014
Aug
, 10 (e1004517).
236
Plant LD
et al.
Individual IKs channels at the surface of mammalian cells contain two KCNE1 accessory subunits.
Proc. Natl. Acad. Sci. U.S.A.,
2014
Apr
8
, 111 (E1438-46).
237
Gong Q
et al.
Position of premature termination codons determines susceptibility of hERG mutations to nonsense-mediated mRNA decay in long QT syndrome.
Gene,
2014
Apr
15
, 539 (190-7).
238
Weeke P
et al.
Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long QT interval syndrome.
J. Am. Coll. Cardiol.,
2014
Apr
15
, 63 (1430-7).
239
Peng D
et al.
Purification and structural study of the voltage-sensor domain of the human KCNQ1 potassium ion channel.
Biochemistry,
2014
Apr
1
, 53 (2032-42).
240
Chadha PS
et al.
Contribution of kv7.4/kv7.5 heteromers to intrinsic and calcitonin gene-related peptide-induced cerebral reactivity.
Arterioscler. Thromb. Vasc. Biol.,
2014
Apr
, 34 (887-93).
241
Wang D
et al.
Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths.
Forensic Sci. Int.,
2014
Apr
, 237 (90-9).
242
Rizzo S
et al.
T-cell-mediated inflammatory activity in the stellate ganglia of patients with ion-channel disease and severe ventricular arrhythmias.
Circ Arrhythm Electrophysiol,
2014
Apr
, 7 (224-9).
243
Wang J
et al.
Association of KCNQ1 and KLF14 polymorphisms and risk of type 2 diabetes mellitus: A global meta-analysis.
Hum. Immunol.,
2014
Apr
, 75 (342-7).
244
Torekov SS
et al.
KCNQ1 long QT syndrome patients have hyperinsulinemia and symptomatic hypoglycemia.
Diabetes,
2014
Apr
, 63 (1315-25).
245
Dvir M
et al.
Recent molecular insights from mutated IKS channels in cardiac arrhythmia.
Curr Opin Pharmacol,
2014
Apr
, 15 (74-82).
246
Tester DJ
et al.
GENETICS OF LONG QT SYNDROME.
Methodist Debakey Cardiovasc J,
2014
1
, 10 (29-33).
247
Kanters JK
et al.
Flecainide provocation reveals concealed brugada syndrome in a long QT syndrome family with a novel L1786Q mutation in SCN5A.
Circ. J.,
2014
, 78 (1136-43).
248
Zaydman MA
et al.
Domain-domain interactions determine the gating, permeation, pharmacology, and subunit modulation of the IKs ion channel.
Elife,
2014
, 3 (e03606).
249
Iyer V
et al.
Modeling Tissue- and Mutation- Specific Electrophysiological Effects in the Long QT Syndrome: Role of the Purkinje Fiber.
PLoS ONE,
2014
, 9 (e97720).
250
Zaydman MA
et al.
PIP2 regulation of KCNQ channels: biophysical and molecular mechanisms for lipid modulation of voltage-dependent gating.
Front Physiol,
2014
, 5 (195).
251
Christiansen M
et al.
Mutations in Danish patients with long QT syndrome and the identification of a large founder family with p.F29L in KCNH2.
BMC Med. Genet.,
2014
, 15 (31).
252
Fröhler S
et al.
Exome sequencing helped the fine diagnosis of two siblings afflicted with atypical Timothy syndrome (TS2).
BMC Med. Genet.,
2014
, 15 (48).
253
Yamaguchi Y
et al.
Glycine/Serine polymorphism at position 38 influences KCNE1 subunit's modulatory actions on rapid and slow delayed rectifier K+ currents.
Circ. J.,
2014
, 78 (610-8).
254
Nielsen JB
et al.
Gain-of-function mutations in potassium channel subunit KCNE2 associated with early-onset lone atrial fibrillation.
Biomark Med,
2014
, 8 (557-70).
255
Yu CC
et al.
Apamin does not inhibit human cardiac Na+ current, L-type Ca2+ current or other major K+ currents.
PLoS ONE,
2014
, 9 (e96691).
256
Villafane J
et al.
Short QT syndrome manifesting with neonatal atrial fibrillation and bradycardia.
Cardiology,
2014
, 128 (236-40).
257
Li P
et al.
Differential modulations of KCNQ1 by auxiliary proteins KCNE1 and KCNE2.
Sci Rep,
2014
, 4 (4973).
258
Takahashi K
et al.
High prevalence of the SCN5A E1784K mutation in school children with long QT syndrome living on the Okinawa islands.
Circ. J.,
2014
, 78 (1974-9).
259
Miller D
et al.
Sodium channels, cardiac arrhythmia, and therapeutic strategy.
Adv. Pharmacol.,
2014
, 70 (367-92).
260
Murphy R
et al.
No evidence for copy number and methylation variation in H19 and KCNQ10T1 imprinting control regions in children born small for gestational age.
BMC Med. Genet.,
2014
, 15 (67).
261
Jimmy JJ
et al.
Clinical characteristics of patients with congenital long QT syndrome and bigenic mutations.
Chin. Med. J.,
2014
, 127 (1482-6).
263
Hennessey JA
et al.
A CACNA1C variant associated with reduced voltage-dependent inactivation, increased CaV1.2 channel window current, and arrhythmogenesis.
PLoS ONE,
2014
, 9 (e106982).
264
Shimizu W
Clinical and genetic diagnosis for inherited cardiac arrhythmias.
J Nippon Med Sch,
2014
, 81 (203-10).
265
Zimmer T
et al.
Voltage-gated sodium channels in the mammalian heart.
Glob Cardiol Sci Pract,
2014
, 2014 (449-63).
266
Gosselin-Badaroudine P
et al.
Nav 1.5 mutations linked to dilated cardiomyopathy phenotypes: Is the gating pore current the missing link?
Channels (Austin),
2014
, 8 (90-4).
267
Guo X
et al.
Discovery of aroyl piperazine derivatives as IKr & IKs dual inhibitors for cardiac arrhythmia treatment.
Med Chem,
2014
, 10 (497-505).
268
Barro-Soria R
et al.
KCNE1 divides the voltage sensor movement in KCNQ1/KCNE1 channels into two steps.
Nat Commun,
2014
, 5 (3750).
269
Bari V
et al.
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1.
PLoS ONE,
2014
, 9 (e93808).
270
Antzelevitch C
et al.
The role of late I Na in development of cardiac arrhythmias.
Handb Exp Pharmacol,
2014
, 221 (137-68).
271
Wu C
et al.
Kcnq1-5 (Kv7.1-5) potassium channel expression in the adult zebrafish.
BMC Physiol.,
2014
, 14 (1).
272
Winbo A
et al.
Phenotype, origin and estimated prevalence of a common long QT syndrome mutation: a clinical, genealogical and molecular genetics study including Swedish R518X/KCNQ1 families.
BMC Cardiovasc Disord,
2014
, 14 (22).
273
Kim SK
et al.
Synergistic restoring effects of isoproterenol and magnesium on KCNQ1-inhibited bradycardia cell models cultured in microelectrode array.
Cardiology,
2014
, 128 (15-24).
274
Fan Z
et al.
Efficient gene targeting in golden Syrian hamsters by the CRISPR/Cas9 system.
PLoS ONE,
2014
, 9 (e109755).
275
Nakajo K
et al.
Steric hindrance between S4 and S5 of the KCNQ1/KCNE1 channel hampers pore opening.
Nat Commun,
2014
, 5 (4100).
276
Mizusawa Y
et al.
Genetic and clinical advances in congenital long QT syndrome.
Circ. J.,
2014
, 78 (2827-33).
277
Coyan FC
et al.
A long QT mutation substitutes cholesterol for phosphatidylinositol-4,5-bisphosphate in KCNQ1 channel regulation.
PLoS ONE,
2014
, 9 (e93255).
278
Anderson CL
et al.
Large-scale mutational analysis of Kv11.1 reveals molecular insights into type 2 long QT syndrome.
Nat Commun,
2014
, 5 (5535).
279
Schweigmann U
et al.
Elevated heart rate triggers action potential alternans and sudden death. translational study of a homozygous KCNH2 mutation.
PLoS ONE,
2014
, 9 (e103150).
280
Liu L
et al.
Chromanol 293B, an inhibitor of KCNQ1 channels, enhances glucose-stimulated insulin secretion and increases glucagon-like peptide-1 level in mice.
Islets,
2014
, 6 (e962386).
281
Strutz-Seebohm N
et al.
Klotho: a new trafficking modifier of Kv7.1/KCNE1 channels.
Channels (Austin),
2014
, 8 (285).
282
Bazzi MD
et al.
Association between FTO, MC4R, SLC30A8, and KCNQ1 gene variants and type 2 diabetes in Saudi population.
Genet. Mol. Res.,
2014
, 13 (10194-203).
283
Almilaji A
et al.
Upregulation of KCNQ1/KCNE1 K+ channels by Klotho.
Channels (Austin),
2014
, 8 (222-9).
284
Ertugrul I
et al.
Follow up of a family with asymptomatic compound long QT syndrome mutations.
Genet. Couns.,
2014
, 25 (399-403).
285
Blom SM
et al.
From pan-reactive KV7 channel opener to subtype selective opener/inhibitor by addition of a methyl group.
PLoS ONE,
2014
, 9 (e100209).
286
Qureshi SF
et al.
Novel mutations of KCNQ1 in Long QT syndrome.
Indian Heart J,
2013 Sep-Oct
, 65 (552-60).
287
Beattie KA
et al.
Evaluation of an in silico cardiac safety assay: Using ion channel screening data to predict QT interval changes in the rabbit ventricular wedge.
J Pharmacol Toxicol Methods,
2013 Jul-Aug
, 68 (88-96).
288
Elkins RC
et al.
Variability in high-throughput ion-channel screening data and consequences for cardiac safety assessment.
J Pharmacol Toxicol Methods,
2013 Jul-Aug
, 68 (112-22).
289
Lang F
et al.
Serum and glucocorticoid inducible kinase, metabolic syndrome, inflammation, and tumor growth.
Hormones (Athens),
2013 Apr-Jun
, 12 (160-71).
290
Svalø J
et al.
Bladder contractility is modulated by Kv7 channels in pig detrusor.
Eur. J. Pharmacol.,
2013
Sep
5
, 715 (312-20).
291
Haugaa KH
et al.
Abnormal electroencephalograms in patients with long QT syndrome.
Heart Rhythm,
2013
Sep
27
, ().
292
Wu M
et al.
Insulin suppresses IKs (KCNQ1/KCNE1) currents, which require β-subunit KCNE1.
Pflugers Arch.,
2013
Sep
26
, ().
293
Diamant UB
et al.
Electrophysiological Phenotype in the LQTS Mutations Y111C and R518X in the KCNQ1 Gene.
J. Appl. Physiol.,
2013
Sep
19
, ().
294
Haitin Y
et al.
The structural mechanism of KCNH-channel regulation by the eag domain.
Nature,
2013
Sep
19
, 501 (444-8).
295
Cordeiro JM
et al.
Developmental changes in expression and biophysics of ion channels in the canine ventricle.
J. Mol. Cell. Cardiol.,
2013
Sep
10
, 64C (79-89).
296
Hedley PL
et al.
The Role of CAV3 in Long QT Syndrome: Clinical and Functional Assessment of a Caveolin-3/Kv11.1 Double Heterozygote Versus Caveolin-3 Single Heterozygote.
Circ Cardiovasc Genet,
2013
Sep
10
, ().
297
Liu C
et al.
Postmortem molecular analysis of KCNQ1, KCNH2, KCNE1 and KCNE2 genes in sudden unexplained nocturnal death syndrome in the Chinese Han population.
Forensic Sci. Int.,
2013
Sep
10
, 231 (82-7).
298
Remme CA
Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects.
J. Physiol. (Lond.),
2013
Sep
1
, 591 (4099-116).
299
Wang H
et al.
Common variants in KCNQ1 confer increased risk of type 2 diabetes and contribute to the diabetic epidemic in East Asians: a replication and meta-analysis.
Ann. Hum. Genet.,
2013
Sep
, 77 (380-91).
300
Laksman ZW
et al.
Mutation location effect on severity of phenotype during exercise testing in type 1 long-QT syndrome: impact of transmembrane and C-loop location.
J. Cardiovasc. Electrophysiol.,
2013
Sep
, 24 (1015-20).
301
Nawathe PA
et al.
An LQTS6 MiRP1 mutation suppresses pacemaker current and is associated with sinus bradycardia.
J. Cardiovasc. Electrophysiol.,
2013
Sep
, 24 (1021-7).
302
Park JK
et al.
Single Nucleotide Deletion Mutation of KCNH2 Gene is Responsible for LQT Syndrome in a 3-Generation Korean Family.
J. Korean Med. Sci.,
2013
Sep
, 28 (1388-93).
303
Yang H
et al.
Compromised potassium recycling in the cochlea contributes to conservation of endocochlear potential in a mouse model of age-related hearing loss.
Neurosci. Lett.,
2013
Oct
25
, 555 (97-101).
304
Kimoto K
et al.
Characterization of a novel mutant KCNQ1 channel subunit lacking a large part of the C-terminal domain.
Biochem. Biophys. Res. Commun.,
2013
Oct
18
, 440 (283-8).
305
Olesen MS
et al.
Very early onset lone atrial fibrillation patients have a high prevalence of rare variants in genes previously associated with atrial fibrillation.
Heart Rhythm,
2013
Oct
18
, ().
306
Ma D
et al.
Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells.
Int. J. Cardiol.,
2013
Oct
15
, 168 (5277-86).
307
Meng J
et al.
Compound ICA-105574 prevents arrhythmias induced by cardiac delayed repolarization.
Eur. J. Pharmacol.,
2013
Oct
15
, 718 (87-97).
308
Hasegawa K
et al.
A Novel KCNQ1 Missense Mutation Identified in a Patient with Juvenile-Onset Atrial Fibrillation Causes Constitutively Open IKs Channels.
Heart Rhythm,
2013
Oct
1
, ().
309
Campbell CM
et al.
Selective targeting of gain-of-function KCNQ1 mutations predisposing to atrial fibrillation.
Circ Arrhythm Electrophysiol,
2013
Oct
, 6 (960-6).
310
Andreasen L
et al.
Genetic Modifier of the QTc Interval Associated With Early-Onset Atrial Fibrillation.
Can J Cardiol,
2013
Oct
, 29 (1234-40).
311
Veerman CC
et al.
Slow delayed rectifier potassium current blockade contributes importantly to drug-induced long QT syndrome.
Circ Arrhythm Electrophysiol,
2013
Oct
, 6 (1002-9).
312
Cuneo BF
et al.
Arrhythmia phenotype during fetal life suggests long-QT syndrome genotype: risk stratification of perinatal long-QT syndrome.
Circ Arrhythm Electrophysiol,
2013
Oct
, 6 (946-51).
313
Giudicessi JR
et al.
Genotype- and Phenotype-Guided Management of Congenital Long QT Syndrome.
Curr Probl Cardiol,
2013
Oct
, 38 (417-455).
314
Wang F
et al.
The phenotype characteristics of type 13 long QT syndrome with mutation in KCNJ5 (Kir3.4-G387R).
Heart Rhythm,
2013
Oct
, 10 (1500-6).
315
Yu W
et al.
Association between KCNQ1 genetic variants and QT interval in a Chinese population.
Diabet. Med.,
2013
Oct
, 30 (1225-9).
316
Lee YS
et al.
Long QT syndrome: a Korean single center study.
J. Korean Med. Sci.,
2013
Oct
, 28 (1454-60).
317
Hummel YM
et al.
Ventricular dysfunction in a family with long QT syndrome type 3.
Europace,
2013
Oct
, 15 (1516-21).
318
Hihara T
et al.
Probucol and the cholesterol synthesis inhibitors simvastatin and triparanol regulate I ks channel function differently.
Hum Exp Toxicol,
2013
Oct
, 32 (1028-37).
319
Bodi I
et al.
Differential effects of the β-adrenoceptor blockers carvedilol and metoprolol on SQT1- and SQT2-mutant channels.
J. Cardiovasc. Electrophysiol.,
2013
Oct
, 24 (1163-71).
320
Kamei S
et al.
Molecular analysis of potassium ion channel genes in sudden death cases among patients administered psychotropic drug therapy: are polymorphisms in LQT genes a potential risk factor?
J. Hum. Genet.,
2013
Nov
28
, ().
321
Li Y
et al.
Intracellular ATP binding is required to activate the slowly activating K+ channel I(Ks).
Proc. Natl. Acad. Sci. U.S.A.,
2013
Nov
19
, 110 (18922-7).
322
Stump MR
et al.
LQT2 nonsense mutations generate trafficking defective NH2-terminally truncated channels by the reinitiation of translation.
Am. J. Physiol. Heart Circ. Physiol.,
2013
Nov
1
, 305 (H1397-404).
323
Smith JL
et al.
Pharmacological correction of long QT-linked mutations in KCNH2 (hERG) increases the trafficking of Kv11.1 channels stored in the transitional endoplasmic reticulum.
Am. J. Physiol., Cell Physiol.,
2013
Nov
1
, 305 (C919-30).
324
Di Cori A
et al.
[Pro-arrhythmic effect of cardiac memory in a patient with long QT syndrome].
G Ital Cardiol (Rome),
2013
Nov
, 14 (746-9).
325
Wan J
et al.
A novel tetranucleotide repeat polymorphism within KCNQ1OT1 confers risk for hepatocellular carcinoma.
DNA Cell Biol.,
2013
Nov
, 32 (628-34).
326
Szlachcic A
et al.
New satiety hormone nesfatin-1 protects gastric mucosa against stress-induced injury: mechanistic roles of prostaglandins, nitric oxide, sensory nerves and vanilloid receptors.
Peptides,
2013
Nov
, 49 (9-20).
327
Zhang X
et al.
KCNQ and KCNE potassium channel subunit expression in bovine retinal pigment epithelium.
Exp. Eye Res.,
2013
Nov
, 116 (424-32).
328
Zhou P
et al.
Phosphatidylinositol 4,5-bisphosphate alters pharmacological selectivity for epilepsy-causing KCNQ potassium channels.
Proc. Natl. Acad. Sci. U.S.A.,
2013
May
21
, 110 (8726-31).
329
Yu H
et al.
Dynamic subunit stoichiometry confers a progressive continuum of pharmacological sensitivity by KCNQ potassium channels.
Proc. Natl. Acad. Sci. U.S.A.,
2013
May
21
, 110 (8732-7).
330
Boczek NJ
et al.
Exome Sequencing and Systems Biology Converge to Identify Novel Mutations in the L-Type Calcium Channel, CACNA1C, Linked to Autosomal Dominant Long QT Syndrome.
Circ Cardiovasc Genet,
2013
May
15
, ().
331
Liu J
et al.
Meta-analysis of the effect of KCNQ1 gene polymorphism on the risk of type 2 diabetes.
Mol. Biol. Rep.,
2013
May
, 40 (3557-67).
332
McBride CM
et al.
Mechanistic basis for type 2 long QT syndrome caused by KCNH2 mutations that disrupt conserved arginine residues in the voltage sensor.
J. Membr. Biol.,
2013
May
, 246 (355-64).
333
An HS
et al.
Sudden cardiac arrest during anesthesia in a 30-month-old boy with syndactyly: a case of genetically proven Timothy syndrome.
J. Korean Med. Sci.,
2013
May
, 28 (788-91).
334
Aziz PF
et al.
Do LQTS gene single nucleotide polymorphisms alter QTc intervals at rest and during exercise stress testing?
Ann Noninvasive Electrocardiol,
2013
May
, 18 (288-93).
335
Khoueiry R
et al.
Abnormal methylation of KCNQ1OT1 and differential methylation of H19 imprinting control regions in human ICSI embryos.
Zygote,
2013
May
, 21 (129-38).
336
Bartos DC
et al.
A KCNQ1 mutation causes a high penetrance for familial atrial fibrillation.
J. Cardiovasc. Electrophysiol.,
2013
May
, 24 (562-9).
337
Hoosien M
et al.
Dysfunctional potassium channel subunit interaction as a novel mechanism of long QT syndrome.
Heart Rhythm,
2013
May
, 10 (728-37).
338
Matsa E
et al.
Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes.
Eur. Heart J.,
2013
Mar
6
, ().
339
Werry D
et al.
Single-channel basis for the slow activation of the repolarizing cardiac potassium current, I(Ks).
Proc. Natl. Acad. Sci. U.S.A.,
2013
Mar
12
, 110 (E996-1005).
340
Chon SJ
et al.
Association of variants in PPARγ², IGF2BP2, and KCNQ1 with a susceptibility to gestational diabetes mellitus in a Korean population.
Yonsei Med. J.,
2013
Mar
1
, 54 (352-7).
341
Babcock JJ
et al.
hERG channel function: beyond long QT.
Acta Pharmacol. Sin.,
2013
Mar
, 34 (329-35).
342
Travers ME
et al.
Insights into the molecular mechanism for type 2 diabetes susceptibility at the KCNQ1 locus from temporal changes in imprinting status in human islets.
Diabetes,
2013
Mar
, 62 (987-92).
343
Jehle J
et al.
Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells.
Br. J. Pharmacol.,
2013
Mar
, 168 (1215-29).
344
Lorente-Cánovas B
et al.
Mice deficient in H+-ATPase a4 subunit have severe hearing impairment associated with enlarged endolymphatic compartments within the inner ear.
Dis Model Mech,
2013
Mar
, 6 (434-42).
345
Lundby A
et al.
In vivo phosphoproteomics analysis reveals the cardiac targets of β-adrenergic receptor signaling.
Sci Signal,
2013
Jun
4
, 6 (rs11).
346
Steinke K
et al.
Coxsackievirus B3 modulates cardiac ion channels.
FASEB J.,
2013
Jun
27
, ().
347
Vaidyanathan R
et al.
The Interaction of Caveolin 3 Protein with the Potassium Inward Rectifier Channel Kir2.1: PHYSIOLOGY AND PATHOLOGY RELATED TO LONG QT SYNDROME 9 (LQT9).
J. Biol. Chem.,
2013
Jun
14
, 288 (17472-80).
348
De La Rosa AJ
et al.
Functional suppression of Kcnq1 leads to early sodium channel remodelling and cardiac conduction system dysmorphogenesis.
Cardiovasc. Res.,
2013
Jun
1
, 98 (504-14).
349
Li J
et al.
Anti-KCNQ1 K⁺ channel autoantibodies increase IKs current and are associated with QT interval shortening in dilated cardiomyopathy.
Cardiovasc. Res.,
2013
Jun
1
, 98 (496-503).
350
Heijman J
et al.
KCNQ1 autoantibodies: another way to regulate IKs.
Cardiovasc. Res.,
2013
Jun
1
, 98 (329-31).
351
Rapetti-Mauss R
et al.
Oestrogen promotes KCNQ1 potassium channel endocytosis and postendocytic trafficking in colonic epithelium.
J. Physiol. (Lond.),
2013
Jun
1
, 591 (2813-31).
352
Winbo A
et al.
Iron-deficiency anaemia, gastric hyperplasia, and elevated gastrin levels due to potassium channel dysfunction in the Jervell and Lange-Nielsen Syndrome.
Cardiol Young,
2013
Jun
, 23 (325-34).
353
Luo Y
et al.
Estrogen-related receptor γ (ERRγ) regulates oxygen-dependent expression of voltage-gated potassium (K+) channels and tissue kallikrein during human trophoblast differentiation.
Mol. Endocrinol.,
2013
Jun
, 27 (940-52).
354
Sachse CC
et al.
BACE1 and presenilin/γ-secretase regulate proteolytic processing of KCNE1 and 2, auxiliary subunits of voltage-gated potassium channels.
FASEB J.,
2013
Jun
, 27 (2458-67).
355
Mahida S
et al.
Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives.
J Interv Card Electrophysiol,
2013
Jun
, 37 (9-19).
356
Lang F
et al.
Therapeutic potential of serum and glucocorticoid inducible kinase inhibition.
Expert Opin Investig Drugs,
2013
Jun
, 22 (701-14).
357
Gravel AE
et al.
An NMR investigation of the structure, function and role of the hERG channel selectivity filter in the long QT syndrome.
Biochim. Biophys. Acta,
2013
Jun
, 1828 (1494-502).
358
Lin YD
et al.
[Association of polymorphisms of potassium voltage-gated channel, KQT-like subfamily, member 1 and type 2 diabetes in Jiangsu province, China].
Zhonghua Yu Fang Yi Xue Za Zhi,
2013
Jun
, 47 (538-41).
359
Brelidze TI
et al.
Structure of the C-terminal region of an ERG channel and functional implications.
Proc. Natl. Acad. Sci. U.S.A.,
2013
Jul
9
, 110 (11648-53).
360
Amin AS
et al.
Long QT syndrome: beyond the causal mutation.
J. Physiol. (Lond.),
2013
Jul
22
, ().
361
Jost N
et al.
Ionic mechanisms limiting cardiac repolarization-reserve in humans compared to dogs.
J. Physiol. (Lond.),
2013
Jul
22
, ().
362
Zaydman MA
et al.
Kv7.1 ion channels require a lipid to couple voltage sensing to pore opening.
Proc. Natl. Acad. Sci. U.S.A.,
2013
Jul
16
, ().
363
Duchatelet S
et al.
Identification of a KCNQ1 Polymorphism Acting as a Protective Modifier against Arrhythmic Risk in Long QT Syndrome.
Circ Cardiovasc Genet,
2013
Jul
15
, ().
364
Takanari H
et al.
Efficient and specific cardiac IK1 inhibition by a new pentamidine analogue.
Cardiovasc. Res.,
2013
Jul
1
, 99 (203-14).
365
Son MK
et al.
Genetic mutation in korean patients of sudden cardiac arrest as a surrogating marker of idiopathic ventricular arrhythmia.
J. Korean Med. Sci.,
2013
Jul
, 28 (1021-6).
366
Varkevisser R
et al.
Structure-activity relationships of pentamidine-affected ion channel trafficking and dofetilide mediated rescue.
Br. J. Pharmacol.,
2013
Jul
, 169 (1322-34).
367
Kaltenbach S
et al.
Beckwith-Wiedemann syndrome and long QT syndrome due to familial-balanced translocation t(11;17)(p15.5;q21.3) involving the KCNQ1 gene.
Clin. Genet.,
2013
Jul
, 84 (78-81).
368
Telezhkin V
et al.
A basic residue in the proximal C-terminus is necessary for efficient activation of the M-channel subunit Kv7.2 by PI(4,5)P₂.
Pflugers Arch.,
2013
Jul
, 465 (945-53).
369
Lieve KV
et al.
Results of genetic testing in 855 consecutive unrelated patients referred for long QT syndrome in a clinical laboratory.
Genet Test Mol Biomarkers,
2013
Jul
, 17 (553-61).
370
Jou CJ
et al.
An In Vivo Cardiac Assay to Determine the Functional Consequences of Putative Long QT Syndrome Mutations.
Circ. Res.,
2013
Jan
9
, ().
371
Nguyen N
et al.
Independent trafficking of the KCNQ1 K+ channel and H+-K+-ATPase in gastric parietal cells from mice.
Am. J. Physiol. Gastrointest. Liver Physiol.,
2013
Jan
15
, 304 (G157-66).
372
Zhang Y
et al.
Arsenic trioxide-induced hERG K(+) channel deficiency can be rescued by matrine and oxymatrine through up-regulating transcription factor Sp1 expression.
Biochem. Pharmacol.,
2013
Jan
1
, 85 (59-68).
373
Feng MJ
et al.
[KCNQ1 mutation in patients with lone atrial fibrillation].
Zhonghua Xin Xue Guan Bing Za Zhi,
2013
Jan
, 41 (8-12).
374
Nakashima K
et al.
A left ventricular noncompaction in a patient with long QT syndrome caused by a KCNQ1 mutation: a case report.
Heart Vessels,
2013
Jan
, 28 (126-9).
375
Lu X
et al.
RNA interference targeting E637K mutation rescues hERG channel currents and restores its kinetic properties.
Heart Rhythm,
2013
Jan
, 10 (128-36).
376
Liu L
et al.
A novel mutation in the transmembrane nonpore region of the KCNH2 gene causes severe clinical manifestations of long QT syndrome.
Heart Rhythm,
2013
Jan
, 10 (61-7).
377
Schneider HE
et al.
Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome.
Clin Res Cardiol,
2013
Jan
, 102 (33-42).
378
Giudicessi JR
et al.
Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes.
Transl Res,
2013
Jan
, 161 (1-14).
379
Terrenoire C
et al.
Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics.
J. Gen. Physiol.,
2013
Jan
, 141 (61-72).
380
Abbott GW
KCNE genetics and pharmacogenomics in cardiac arrhythmias: much ado about nothing?
Expert Rev Clin Pharmacol,
2013
Jan
, 6 (49-60).
381
Zhang A
et al.
L539 fs/47, a truncated mutation of human ether-a-go-go-related gene (hERG), decreases hERG ion channel currents in HEK 293 cells.
Clin. Exp. Pharmacol. Physiol.,
2013
Jan
, 40 (28-36).
382
Lang F
et al.
Regulation of ion channels by the serum- and glucocorticoid-inducible kinase SGK1.
FASEB J.,
2013
Jan
, 27 (3-12).
383
Bostan O
et al.
Jervell and Lange-Nielsen Syndrome: Homozygous Missense Mutation of KCNQ1 in a Turkish Family.
Pediatr Cardiol,
2013
Feb
12
, ().
384
Ruscic KJ
et al.
IKs channels open slowly because KCNE1 accessory subunits slow the movement of S4 voltage sensors in KCNQ1 pore-forming subunits.
Proc. Natl. Acad. Sci. U.S.A.,
2013
Feb
12
, 110 (E559-66).
385
Yang T
et al.
An Allosteric Mechanism for Drug Block of the Human Cardiac Potassium Channel KCNQ1.
Mol. Pharmacol.,
2013
Feb
, 83 (481-9).
386
Melnick M
et al.
An in vitro mouse model of congenital cytomegalovirus-induced pathogenesis of the inner ear cochlea.
Birth Defects Res. Part A Clin. Mol. Teratol.,
2013
Feb
, 97 (69-78).
387
De Crescenzo A
et al.
Paternal deletion of the 11p15.5 centromeric-imprinting control region is associated with alteration of imprinted gene expression and recurrent severe intrauterine growth restriction.
J. Med. Genet.,
2013
Feb
, 50 (99-103).
388
Siraskar B
et al.
Downregulation of the renal outer medullary K(+) channel ROMK by the AMP-activated protein kinase.
Pflugers Arch.,
2013
Feb
, 465 (233-45).
389
Ware JS
et al.
Next generation diagnostics in inherited arrhythmia syndromes : a comparison of two approaches.
J Cardiovasc Transl Res,
2013
Feb
, 6 (94-103).
390
Wang Y
et al.
[Ca2+]i elevation and oxidative stress induce KCNQ1 protein translocation from the cytosol to the cell surface and increase slow delayed rectifier (IKs) in cardiac myocytes.
J. Biol. Chem.,
2013
Dec
6
, 288 (35358-71).
391
Nguyen HL
et al.
Andersen-Tawil syndrome: clinical and molecular aspects.
Int. J. Cardiol.,
2013
Dec
5
, 170 (1-16).
392
Xu Y
et al.
Building KCNQ1/KCNE1 channel models and probing their interactions by molecular-dynamics simulations.
Biophys. J.,
2013
Dec
3
, 105 (2461-73).
393
Seebohm G
A complex partnership: KCNQ1 and KCNE1.
Biophys. J.,
2013
Dec
3
, 105 (2437-8).
394
Andersen MN
et al.
A Phosphoinositide 3-Kinase (PI3K)-serum- and glucocorticoid-inducible Kinase 1 (SGK1) Pathway Promotes Kv7.1 Channel Surface Expression by Inhibiting Nedd4-2 Protein.
J. Biol. Chem.,
2013
Dec
27
, 288 (36841-54).
395
Bellin M
et al.
Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome.
EMBO J.,
2013
Dec
11
, 32 (3161-75).
396
Uesugi M
et al.
Low-density plating is sufficient to induce cardiac hypertrophy and electrical remodeling in highly purified human iPS cell-derived cardiomyocytes.
J Pharmacol Toxicol Methods,
2013
Dec
1
, ().
397
Khanamiri S
et al.
Contribution of Kv7 channels to basal coronary flow and active response to ischemia.
Hypertension,
2013
Dec
, 62 (1090-7).
398
Hintsa T
et al.
Work stress and the long QT syndrome: high job strain and effort-reward imbalance at work associated with arrhythmic risk in the long QT syndrome.
J. Occup. Environ. Med.,
2013
Dec
, 55 (1387-93).
399
Apaja PM
et al.
Ubiquitination-dependent quality control of hERG K+ channel with acquired and inherited conformational defect at the plasma membrane.
Mol. Biol. Cell,
2013
Dec
, 24 (3787-804).
400
Kato K
et al.
Cardiac Channelopathies Associated with Infantile Fatal Ventricular Arrhythmias: From the Cradle to the Bench.
J. Cardiovasc. Electrophysiol.,
2013
Aug
26
, ().
401
Than BL
et al.
The role of KCNQ1 in mouse and human gastrointestinal cancers.
Oncogene,
2013
Aug
26
, ().
402
Hayashi M
et al.
Molecular basis of potassium channels in pancreatic duct epithelial cells.
Channels (Austin),
2013
Aug
20
, 7 ().
403
Li Y
et al.
MicroRNA-1/133 targeted dysfunction of potassium channels KCNE1 and KCNQ1 in human cardiac progenitor cells with simulated hyperglycemia.
Int. J. Cardiol.,
2013
Aug
10
, 167 (1076-8).
404
Gao Y
et al.
A novel deletion-frameshift mutation in the S1 region of HERG gene in a Chinese family with long QT syndrome.
Chin. Med. J.,
2013
Aug
, 126 (3093-6).
405
Cheng J
et al.
Caveolin-3 suppresses late sodium current by inhibiting nNOS-dependent S-nitrosylation of SCN5A.
J. Mol. Cell. Cardiol.,
2013
Aug
, 61 (102-10).
406
Lee HC
et al.
Modulation of KCNQ1 alternative splicing regulates cardiac IKs and action potential repolarization.
Heart Rhythm,
2013
Aug
, 10 (1220-8).
407
Thomsen MB
Kv7.1 isoform gradients in the heart: new potential approach to alter repolarization reserve.
Heart Rhythm,
2013
Aug
, 10 (1229-30).
408
Maslarova A
et al.
Increased susceptibility to acetylcholine in the entorhinal cortex of pilocarpine-treated rats involves alterations in KCNQ channels.
Neurobiol. Dis.,
2013
Aug
, 56 (14-24).
409
Hanson RL
et al.
Strong parent-of-origin effects in the association of KCNQ1 variants with type 2 diabetes in American Indians.
Diabetes,
2013
Aug
, 62 (2984-91).
410
Tsai WC
et al.
Ablation of the androgen receptor gene modulates atrial electrophysiology and arrhythmogenesis with calcium protein dysregulation.
Endocrinology,
2013
Aug
, 154 (2833-42).
411
Partemi S
et al.
Loss-of-function KCNH2 mutation in a family with long QT syndrome, epilepsy, and sudden death.
Epilepsia,
2013
Aug
, 54 (e112-6).
412
Arslan Yildiz A
et al.
Biomimetic membrane platform containing hERG potassium channel and its application to drug screening.
Analyst,
2013
Apr
7
, 138 (2007-12).
413
de Pascual R
et al.
Lower density of L-type and higher density of P/Q-type of calcium channels in chromaffin cells of hypertensive, compared with normotensive rats.
Eur. J. Pharmacol.,
2013
Apr
15
, 706 (25-35).
414
Crotti L
et al.
Long QT syndrome-associated mutations in intrauterine fetal death.
JAMA,
2013
Apr
10
, 309 (1473-82).
415
Hu RM
et al.
Digenic inheritance novel mutations in SCN5a and SNTA1 increase late I(Na) contributing to LQT syndrome.
Am. J. Physiol. Heart Circ. Physiol.,
2013
Apr
1
, 304 (H994-H1001).
416
Gao M
et al.
An altered expression of genes involved in the regulation of ion channels in atrial myocytes is correlated with the risk of atrial fibrillation in patients with heart failure.
Exp Ther Med,
2013
Apr
, 5 (1239-1243).
417
Shinwari ZM
et al.
Identification of a novel KCNQ1 mutation in a large Saudi family with long QT syndrome: clinical consequences and preventive implications.
Clin. Genet.,
2013
Apr
, 83 (370-4).
418
Giudicessi JR
et al.
Prevalence and potential genetic determinants of sensorineural deafness in KCNQ1 homozygosity and compound heterozygosity.
Circ Cardiovasc Genet,
2013
Apr
, 6 (193-200).
419
Netchine I
et al.
Epigenetic anomalies in childhood growth disorders.
Nestle Nutr Inst Workshop Ser,
2013
, 71 (65-73).
420
Trolle C
et al.
Long QT interval in Turner syndrome--a high prevalence of LQTS gene mutations.
PLoS ONE,
2013
, 8 (e69614).
421
Theilade J
et al.
Cascade screening in families with inherited cardiac diseases driven by cardiologists: feasibility and nationwide outcome in long QT syndrome.
Cardiology,
2013
, 126 (131-7).
422
Afeli SA
et al.
Molecular expression and pharmacological evidence for a functional role of kv7 channel subtypes in Guinea pig urinary bladder smooth muscle.
PLoS ONE,
2013
, 8 (e75875).
423
Strutz-Seebohm N
et al.
A Common Structural Component for β-Subunit Mediated Modulation of Slow Inactivation in Different KV Channels.
Cell. Physiol. Biochem.,
2013
, 31 (968-80).
424
Hua Z
et al.
Chemical derivatization and purification of peptide-toxins for probing ion channel complexes.
Methods Mol. Biol.,
2013
, 995 (19-30).
425
Hsiao PY
et al.
Gene mutations in cardiac arrhythmias: a review of recent evidence in ion channelopathies.
Appl Clin Genet,
2013
, 6 (1-13).
426
Li X
et al.
Endolymphatic Na(+) and K(+) Concentrations during Cochlear Growth and Enlargement in Mice Lacking Slc26a4/pendrin.
PLoS ONE,
2013
, 8 (e65977).
427
Vyas V
et al.
The investigation of sudden arrhythmic death syndrome (SADS)-the current approach to family screening and the future role of genomics and stem cell technology.
Front Physiol,
2013
, 4 (199).
428
Shimizu W
Update of diagnosis and management of inherited cardiac arrhythmias.
Circ. J.,
2013
, 77 (2867-72).
429
Fan Y
et al.
Genistein ameliorates adverse cardiac effects induced by arsenic trioxide through preventing cardiomyocytes apoptosis.
Cell. Physiol. Biochem.,
2013
, 31 (80-91).
430
Chu HM
et al.
Polymorphisms but not mutations of the KCNQ1 gene are associated with lone atrial fibrillation in the Chinese Han population.
ScientificWorldJournal,
2013
, 2013 (373454).
431
Moric-Janiszewska E
et al.
Quantitative PCR as an Alternative in the Diagnosis of Long-QT Syndrome.
Biomed Res Int,
2013
, 2013 (418604).
432
Stolk L
et al.
Epigenetic profiles in children with a neural tube defect; a case-control study in two populations.
PLoS ONE,
2013
, 8 (e78462).
433
Fatima A
et al.
The disease-specific phenotype in cardiomyocytes derived from induced pluripotent stem cells of two long QT syndrome type 3 patients.
PLoS ONE,
2013
, 8 (e83005).
434
Kosenko A
et al.
A change in configuration of the calmodulin-KCNQ channel complex underlies Ca2+-dependent modulation of KCNQ channel activity.
PLoS ONE,
2013
, 8 (e82290).
435
Shu L
et al.
Modulation of HERG K+ channels by chronic exposure to activators and inhibitors of PKA and PKC: actions independent of PKA and PKC phosphorylation.
Cell. Physiol. Biochem.,
2013
, 32 (1830-44).
436
Uziębło-Życzkowska B
et al.
Congenital long QT syndrome of particularly malignant course connected with so far unknown mutation in the sodium channel SCN5A gene.
Cardiol J,
2013
, 20 (78-82).
437
Pérez Riera AR
et al.
Congenital short QT syndrome: landmarks of the newest arrhythmogenic cardiac channelopathy.
Cardiol J,
2013
, 20 (464-71).
438
Okata S
et al.
The generation of induced pluripotent stem cells from a patient with KCNH2 G603D, without LQT2 disease associated symptom.
J. Med. Dent. Sci.,
2013
, 60 (17-22).
439
Ferrer T
et al.
Tamoxifen inhibition of kv7.2/kv7.3 channels.
PLoS ONE,
2013
, 8 (e76085).
440
Andrsova I
et al.
Clinical characteristics of 30 Czech families with long QT syndrome and KCNQ1 and KCNH2 gene mutations: importance of exercise testing.
J Electrocardiol,
2012 Nov-Dec
, 45 (746-51).
441
Lin L
et al.
Drug-induced QT-interval prolongation and recurrent torsade de pointes in a child with heterotaxy syndrome and KCNE1 D85N polymorphism.
J Electrocardiol,
2012 Nov-Dec
, 45 (770-3).
442
Hekkala AM
et al.
T-wave morphology after epinephrine bolus may reveal silent long QT syndrome mutation carriers.
J Electrocardiol,
2012 Jul-Aug
, 45 (368-72).
443
Jindal HK
et al.
Proteomic analyses of transgenic LQT1 and LQT2 rabbit hearts elucidate an increase in expression and activity of energy producing enzymes.
J Proteomics,
2012
Sep
18
, 75 (5254-65).
444
Kharche S
et al.
Pro-arrhythmogenic effects of the S140G KCNQ1 mutation in human atrial fibrillation - insights from modelling.
J. Physiol. (Lond.),
2012
Sep
15
, 590 (4501-14).
445
Mattmann ME
et al.
Identification of (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide, ML277, as a novel, potent and selective K(v)7.1 (KCNQ1) potassium channel activator.
Bioorg. Med. Chem. Lett.,
2012
Sep
15
, 22 (5936-41).
446
Odgerel Z
et al.
Genetic variants in potassium channels are associated with type 2 diabetes in a Mongolian population.
J Diabetes,
2012
Sep
, 4 (238-42).
447
Zumhagen S
et al.
Inherited long QT syndrome: clinical manifestation, genetic diagnostics, and therapy.
Herzschrittmacherther Elektrophysiol,
2012
Sep
, 23 (211-9).
448
Wijnen M
et al.
KCNQ1OT1 hypomethylation: a novel disguised genetic predisposition in sporadic pediatric adrenocortical tumors?
Pediatr Blood Cancer,
2012
Sep
, 59 (565-6).
449
Korostowski L
et al.
The Kcnq1ot1 long non-coding RNA affects chromatin conformation and expression of Kcnq1, but does not regulate its imprinting in the developing heart.
PLoS Genet.,
2012
Sep
, 8 (e1002956).
450
Lim XL
et al.
KCNQ1 SNPS and susceptibility to diabetic nephropathy in East Asians with type 2 diabetes.
Diabetologia,
2012
Sep
, 55 (2402-6).
451
Peng HH
et al.
DNA methylation patterns of imprinting centers for H19, SNRPN, and KCNQ1OT1 in single-cell clones of human amniotic fluid mesenchymal stem cell.
Taiwan J Obstet Gynecol,
2012
Sep
, 51 (342-9).
452
Meisel E
et al.
KCNQ1 channels do not undergo concerted but sequential gating transitions in both the absence and the presence of KCNE1 protein.
J. Biol. Chem.,
2012
Oct
5
, 287 (34212-24).
453
Haugaa KH
et al.
Subclinical Cardiomyopathy and Long QT Syndrome: An Echocardiographic Observation.
Congenit Heart Dis,
2012
Oct
24
, ().
454
Abderemane-Ali F
et al.
Dual effect of phosphatidyl (4,5)-bisphosphate PIP2 on Shaker K+ channels.
J. Biol. Chem.,
2012
Oct
19
, 287 (36158-67).
455
Song W
et al.
The human Nav1.5 F1486 deletion associated with long QT syndrome leads to impaired sodium channel inactivation and reduced lidocaine sensitivity.
J. Physiol. (Lond.),
2012
Oct
15
, 590 (5123-39).
456
Giudicessi JR
et al.
Phylogenetic and physicochemical analyses enhance the classification of rare nonsynonymous single nucleotide variants in type 1 and 2 long-QT syndrome.
Circ Cardiovasc Genet,
2012
Oct
1
, 5 (519-28).
457
Chu W
et al.
Arsenic-induced interstitial myocardial fibrosis reveals a new insight into drug-induced long QT syndrome.
Cardiovasc. Res.,
2012
Oct
1
, 96 (90-8).
458
Föller M
et al.
AMP-activated protein kinase in BK-channel regulation and protection against hearing loss following acoustic overstimulation.
FASEB J.,
2012
Oct
, 26 (4243-53).
459
Winkel BG
et al.
The prevalence of mutations in KCNQ1, KCNH2, and SCN5A in an unselected national cohort of young sudden unexplained death cases.
J. Cardiovasc. Electrophysiol.,
2012
Oct
, 23 (1092-8).
460
Mannino GC
et al.
Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.
Mol Diagn Ther,
2012
Oct
, 16 (285-302).
461
Yu W
et al.
Association between KCNQ1 genetic variants and obesity in Chinese patients with type 2 diabetes.
Diabetologia,
2012
Oct
, 55 (2655-9).
462
Zhao QH
et al.
[KCNQ1, KCNH2, KCNE1 and KCNE2 potassium channels gene variants in sudden manhood death syndrome].
Fa Yi Xue Za Zhi,
2012
Oct
, 28 (337-41, 346).
463
Hoefen R
et al.
In silico cardiac risk assessment in patients with long QT syndrome: type 1: clinical predictability of cardiac models.
J. Am. Coll. Cardiol.,
2012
Nov
20
, 60 (2182-91).
464
Burgess DE
et al.
High-risk long QT syndrome mutations in the Kv7.1 (KCNQ1) pore disrupt the molecular basis for rapid K(+) permeation.
Biochemistry,
2012
Nov
13
, 51 (9076-85).
465
Duehmke RM
et al.
Altered re-excitation thresholds and conduction of extrasystolic action potentials contribute to arrhythmogenicity in murine models of long QT syndrome.
Acta Physiol (Oxf),
2012
Nov
, 206 (164-77).
466
Edelmann J
et al.
Long QT syndrome mutation detection by SNaPshot technique.
Int. J. Legal Med.,
2012
Nov
, 126 (969-73).
467
Stump MR
et al.
Early LQT2 nonsense mutation generates N-terminally truncated hERG channels with altered gating properties by the reinitiation of translation.
J. Mol. Cell. Cardiol.,
2012
Nov
, 53 (725-33).
468
Abriel H
Cardiac Sodium Channel Nav1.5 Mechanosensitivity is Inhibited by Ranolazine.
,
2012
May
7
, ().
469
Donovan AJ
et al.
LQT2 Mutation on the Kv11.1 Ion Channel Inhibits Current Activity by Ablating a PKCα Consensus Site.
,
2012
May
31
, ().
470
Du YM
et al.
18β-Glycyrrhetinic acid preferentially blocks late Na current generated by ΔKPQ Nav1.5 channels.
,
2012
May
21
, ().
472
Osteen JD
et al.
Allosteric gating mechanism underlies the flexible gating of KCNQ1 potassium channels.
Proc. Natl. Acad. Sci. U.S.A.,
2012
May
1
, 109 (7103-8).
473
Harmer SC
et al.
Readthrough of long-QT syndrome type 1 nonsense mutations rescues function but alters the biophysical properties of the channel.
Biochem. J.,
2012
May
1
, 443 (635-42).
474
Birner C
et al.
Differential expression of potassium channels and abnormal conduction in experimental tachycardia-induced heart failure.
Naunyn Schmiedebergs Arch. Pharmacol.,
2012
May
, 385 (473-80).
475
Chen J
et al.
Binding interface of cardiac potassium channel proteins identified by hydrogen deuterium exchange of synthetic peptides.
Anal Bioanal Chem,
2012
May
, 403 (1303-9).
476
Smushkin G
et al.
Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1.
Diabetes,
2012
May
, 61 (1082-9).
477
Kapoor S
Beyond diabetes mellitus: close pathological association of mutations of the KCNQ1 gene with other systemic disorders.
Ann. Acad. Med. Singap.,
2012
May
, 41 (233).
478
Dai XP
et al.
KCNQ1 gene polymorphisms are associated with the therapeutic efficacy of repaglinide in Chinese type 2 diabetic patients.
Clin. Exp. Pharmacol. Physiol.,
2012
May
, 39 (462-8).
479
Saint-Criq V
et al.
Estrogen regulation of epithelial ion transport: Implications in health and disease.
,
2012
Mar
5
, ().
480
481
482
Liu GX
et al.
Differential conditions for early after-depolarizations and triggered activity in cardiomyocytes derived from transgenic LQT1 and LQT2 rabbits.
J. Physiol. (Lond.),
2012
Mar
1
, 590 (1171-80).
483
Pattnaik BR
et al.
Effects of KCNQ channel modulators on the M-type potassium current in primate retinal pigment epithelium.
Am. J. Physiol., Cell Physiol.,
2012
Mar
, 302 (C821-33).
484
Moreno JD
et al.
Pathophysiology of the cardiac late Na current and its potential as a drug target.
J. Mol. Cell. Cardiol.,
2012
Mar
, 52 (608-19).
485
Besana A
et al.
Nadolol block of Nav1.5 does not explain its efficacy in the long QT syndrome.
J. Cardiovasc. Pharmacol.,
2012
Mar
, 59 (249-53).
486
Chang YC
et al.
Replication of genome-wide association signals of type 2 diabetes in Han Chinese in a prospective cohort.
Clin. Endocrinol. (Oxf),
2012
Mar
, 76 (365-72).
487
Amin AS
et al.
Variants in the 3' untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner.
Eur. Heart J.,
2012
Mar
, 33 (714-23).
488
Krzystanek K
et al.
Deubiquitylating enzyme USP2 counteracts Nedd4-2-mediated downregulation of KCNQ1 potassium channels.
Heart Rhythm,
2012
Mar
, 9 (440-8).
489
Kaddar N
et al.
Tizanidine (Zanaflex): a muscle relaxant that may prolong the QT interval by blocking IKr.
J. Cardiovasc. Pharmacol. Ther.,
2012
Mar
, 17 (102-9).
490
Gönczi M
et al.
Age-dependent changes in ion channel mRNA expression in canine cardiac tissues.
Gen. Physiol. Biophys.,
2012
Jun
, 31 (153-62).
491
Tester DJ
et al.
Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing.
Mayo Clin. Proc.,
2012
Jun
, 87 (524-39).
492
Parikh A
et al.
Ranolazine stabilizes cardiac ryanodine receptors: a novel mechanism for the suppression of early afterdepolarization and torsades de pointes in long QT type 2.
Heart Rhythm,
2012
Jun
, 9 (953-60).
493
Costa J
et al.
Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome.
Heart Rhythm,
2012
Jun
, 9 (892-8).
494
495
Gofman Y
et al.
How Does KCNE1 Regulate the Kv7.1 Potassium Channel? Model-Structure, Mutations, and Dynamics of the Kv7.1-KCNE1 Complex.
,
2012
Jul
3
, ().
496
Kulzer M
et al.
Inhibition of cardiac Kir2.1-2.3 channels by beta3 adrenoreceptor antagonist SR 59230A.
Biochem. Biophys. Res. Commun.,
2012
Jul
27
, 424 (315-20).
497
Egashira T
et al.
Disease characterization using LQTS-specific induced pluripotent stem cells.
,
2012
Jul
24
, ().
498
Zhang H
et al.
Modulation of hERG potassium channel gating normalizes action potential duration prolonged by dysfunctional KCNQ1 potassium channel.
Proc. Natl. Acad. Sci. U.S.A.,
2012
Jul
17
, 109 (11866-71).
499
Hayashi M
et al.
An intermediate-conductance Ca2+-activated K+ channel is important for secretion in pancreatic duct cells.
Am. J. Physiol., Cell Physiol.,
2012
Jul
15
, 303 (C151-9).
500
Hammami S
et al.
Purinergic signalling - a possible mechanism for KCNQ1 channel response to cell volume challenges.
,
2012
Jul
14
, ().
501
Ritchie MD
et al.
Chromosome 4q25 Variants Are Genetic Modifiers of Rare Ion Channel Mutations Associated With Familial Atrial Fibrillation.
,
2012
Jul
10
, ().
502
Crotti L
et al.
Torsades de pointes following acute myocardial infarction: evidence for a deadly link with a common genetic variant.
Heart Rhythm,
2012
Jul
, 9 (1104-12).
503
Farrugia A
et al.
Detection of genetic variation in KCNQ1 gene by high-resolution melting analysis in a prospective-based series of postmortem negative sudden death: comparison of results obtained in fresh frozen and formalin-fixed paraffin-embedded tissues.
Int. J. Legal Med.,
2012
Jul
, 126 (649-57).
504
Rosengren AH
et al.
Reduced insulin exocytosis in human pancreatic β-cells with gene variants linked to type 2 diabetes.
Diabetes,
2012
Jul
, 61 (1726-33).
505
Vandenberg JI
et al.
hERG K(+) channels: structure, function, and clinical significance.
Physiol. Rev.,
2012
Jul
, 92 (1393-478).
506
Bardou O
et al.
K+ channels regulate ENaC expression via changes in promoter activity and control fluid clearance in alveolar epithelial cells.
Biochim. Biophys. Acta,
2012
Jul
, 1818 (1682-90).
507
Gunthorpe MJ
et al.
The mechanism of action of retigabine (ezogabine), a first-in-class K(+) channel opener for the treatment of epilepsy.
,
2012
Jan
5
, ().
508
Heijman J
et al.
Dominant-negative control of cAMP-dependent IKs upregulation in human long-QT syndrome type 1.
Circ. Res.,
2012
Jan
20
, 110 (211-9).
509
Chadha PS
et al.
Pharmacological dissection of K(v) 7.1 channels in systemic and pulmonary arteries.
,
2012
Jan
17
, ().
510
Guseva N
et al.
Antisense noncoding RNA promoter regulates the timing of de novo methylation of an imprinting control region.
Dev. Biol.,
2012
Jan
15
, 361 (403-11).
511
Chiesa N
et al.
The KCNQ1OT1 imprinting control region and non-coding RNA: new properties derived from the study of Beckwith-Wiedemann syndrome and Silver-Russell syndrome cases.
Hum. Mol. Genet.,
2012
Jan
1
, 21 (10-25).
512
Andersen MN
et al.
AMP-activated protein kinase downregulates Kv7.1 cell surface expression.
Traffic,
2012
Jan
, 13 (143-56).
513
Krishnan Y
et al.
Partially dominant mutant channel defect corresponding with intermediate LQT2 phenotype.
Pacing Clin Electrophysiol,
2012
Jan
, 35 (3-16).
514
Puppala D
et al.
Comparative gene expression profiling in human-induced pluripotent stem cell--derived cardiocytes and human and cynomolgus heart tissue.
Toxicol. Sci.,
2012
Jan
, 131 (292-301).
515
Kauferstein S
et al.
Cardiac channelopathy causing sudden death as revealed by molecular autopsy.
,
2012
Feb
28
, ().
516
Aidery P
et al.
Identification and functional characterization of the novel human ether-a-go-go-related gene (hERG) R744P mutant associated with hereditary long QT syndrome 2.
Biochem. Biophys. Res. Commun.,
2012
Feb
24
, 418 (830-5).
517
Yang X
et al.
Oestrogen upregulates L-type Ca²⁺ channels via oestrogen-receptor- by a regional genomic mechanism in female rabbit hearts.
J. Physiol. (Lond.),
2012
Feb
1
, 590 (493-508).
518
Lang F
et al.
Serum- and glucocorticoid-inducible kinase 1 in the regulation of renal and extrarenal potassium transport.
Clin. Exp. Nephrol.,
2012
Feb
, 16 (73-80).
519
Dennis AT
et al.
Molecular determinants of pentamidine-induced hERG trafficking inhibition.
Mol. Pharmacol.,
2012
Feb
, 81 (198-209).
520
Mayo S
et al.
Hypomethylation of the KCNQ1OT1 imprinting center of chromosome 11 associated to Sotos-like features.
J. Hum. Genet.,
2012
Feb
, 57 (153-6).
521
Chan PJ
et al.
Characterization of KCNQ1 atrial fibrillation mutations reveals distinct dependence on KCNE1.
J. Gen. Physiol.,
2012
Feb
, 139 (135-44).
522
O'Hara T
et al.
Arrhythmia formation in subclinical ("silent") long QT syndrome requires multiple insults: quantitative mechanistic study using the KCNQ1 mutation Q357R as example.
Heart Rhythm,
2012
Feb
, 9 (275-82).
523
Pareja K
et al.
Role of the activation gate in determining the extracellular potassium dependency of block of HERG by trapped drugs.
Channels (Austin),
2012
Dec
6
, 7 ().
524
Abriel H
et al.
Cardiac channelopathies: Genetic and molecular mechanisms.
Gene,
2012
Dec
22
, ().
525
Ishii K
et al.
Endocytic regulation of voltage-dependent potassium channels in the heart.
J. Pharmacol. Sci.,
2012
Dec
18
, 120 (264-9).
526
Friedrichs S
et al.
Modeling long QT syndromes using induced pluripotent stem cells: Current progress and future challenges.
Trends Cardiovasc. Med.,
2012
Dec
18
, ().
527
Organ-Darling LE
et al.
Interactions between hERG and KCNQ1 α-subunits are mediated by their C-termini and modulated by cAMP.
Am. J. Physiol. Heart Circ. Physiol.,
2012
Dec
15
, ().
528
Aidery P
et al.
Impaired ion channel function related to a common KCNQ1 mutation - implications for risk stratification in long QT syndrome 1.
Gene,
2012
Dec
10
, 511 (26-33).
529
Gaunt TR
et al.
Integration of Genetics into a Systems Model of Electrocardiographic Traits Using HumanCVD BeadChip.
Circ Cardiovasc Genet,
2012
Dec
1
, 5 (630-8).
530
Long J
et al.
Evaluation of genome-wide association study-identified type 2 diabetes loci in African Americans.
Am. J. Epidemiol.,
2012
Dec
1
, 176 (995-1001).
531
Wang Y
et al.
Probing the structural basis for differential KCNQ1 modulation by KCNE1 and KCNE2.
J. Gen. Physiol.,
2012
Dec
, 140 (653-69).
532
Turki A
et al.
Lack of association between genetic polymorphisms within KCNQ1 locus and type 2 diabetes in Tunisian Arabs.
Diabetes Res. Clin. Pract.,
2012
Dec
, 98 (452-8).
533
Winbo A
et al.
Prevalence, mutation spectrum, and cardiac phenotype of the Jervell and Lange-Nielsen syndrome in Sweden.
Europace,
2012
Dec
, 14 (1799-806).
534
Gamboa-Meléndez MA
et al.
Contribution of common genetic variation to the risk of type 2 diabetes in the Mexican Mestizo population.
Diabetes,
2012
Dec
, 61 (3314-21).
535
Fedoriw AM
et al.
Differentiation-driven nucleolar association of the mouse imprinted Kcnq1 locus.
G3 (Bethesda),
2012
Dec
, 2 (1521-8).
536
Olesen MS
et al.
High prevalence of long QT syndrome-associated SCN5A variants in patients with early-onset lone atrial fibrillation.
Circ Cardiovasc Genet,
2012
Aug
1
, 5 (450-9).
537
Song W
et al.
Cardiac sodium channel Nav1.5 mutations and cardiac arrhythmia.
Pediatr Cardiol,
2012
Aug
, 33 (943-9).
538
Wang M
et al.
Stoichiometry of the slow I(ks) potassium channel in human embryonic stem cell-derived myocytes.
Pediatr Cardiol,
2012
Aug
, 33 (938-42).
539
Iwata M
et al.
Genetic risk score constructed using 14 susceptibility alleles for type 2 diabetes is associated with the early onset of diabetes and may predict the future requirement of insulin injections among Japanese individuals.
Diabetes Care,
2012
Aug
, 35 (1763-70).
540
Mohammad F
et al.
Long noncoding RNA-mediated maintenance of DNA methylation and transcriptional gene silencing.
Development,
2012
Aug
, 139 (2792-803).
541
Ware JS
et al.
Paralogous annotation of disease-causing variants in long QT syndrome genes.
Hum. Mutat.,
2012
Aug
, 33 (1188-91).
542
Purtell K
et al.
The KCNQ1-KCNE2 K⁺ channel is required for adequate thyroid I⁻ uptake.
FASEB J.,
2012
Aug
, 26 (3252-9).
543
Chinushi M
et al.
Exercise-related QT interval shortening with a peaked T wave in a healthy boy with a family history of sudden cardiac death.
Pacing Clin Electrophysiol,
2012
Aug
, 35 (e239-42).
544
Jiménez-Vargas JM
et al.
Toxin modulators and blockers of hERG K(+) channels.
,
2012
Apr
5
, ().
545
Liu X
et al.
Characterization of A-935142, a hERG enhancer, in the presence and absence of standard hERG blockers.
Life Sci.,
2012
Apr
20
, 90 (607-11).
546
Zamorano-León JJ
et al.
KCNH2 Gene Mutation: A Potential Link Between Epilepsy and Long QT-2 Syndrome.
,
2012
Apr
19
, ().
547
Abd Allah ES
et al.
Postnatal development of transmural gradients in expression of ion channels and Ca(2+)-handling proteins in the ventricle.
,
2012
Apr
17
, ().
548
Vigneault P
et al.
Galantamine (Reminyl) delays cardiac ventricular repolarization and prolongs the QT interval by blocking the HERG current.
Eur. J. Pharmacol.,
2012
Apr
15
, 681 (68-74).
549
Park SE
et al.
Impact of common type 2 diabetes risk gene variants on future type 2 diabetes in the non-diabetic population in Korea.
J. Hum. Genet.,
2012
Apr
, 57 (265-8).
550
Chadha PS
et al.
Reduced KCNQ4-encoded voltage-dependent potassium channel activity underlies impaired β-adrenoceptor-mediated relaxation of renal arteries in hypertension.
Hypertension,
2012
Apr
, 59 (877-84).
551
Murphy LL
et al.
Developmentally regulated SCN5A splice variant potentiates dysfunction of a novel mutation associated with severe fetal arrhythmia.
Heart Rhythm,
2012
Apr
, 9 (590-7).
552
Couderc JP
et al.
Genotype- and Sex-Specific QT-RR Relationship in the Type-1 Long-QT Syndrome.
J Am Heart Assoc,
2012
Apr
, 1 (e000570).
553
Komarlu R
et al.
Fetal and neonatal presentation of long QT syndrome.
Pacing Clin Electrophysiol,
2012
Apr
, 35 (e87-90).
554
Lazarczyk MJ
et al.
Selective acquired long QT syndrome (saLQTS) upon risperidone treatment.
BMC Psychiatry,
2012
, 12 (220).
555
Xu XH
et al.
Allitridi inhibits multiple cardiac potassium channels expressed in HEK 293 cells.
PLoS ONE,
2012
, 7 (e51550).
556
Knoche JW
et al.
Atrial Fibrillation and Long QT Syndrome Presenting in a 12-Year-Old Girl.
Case Rep Pediatr,
2012
, 2012 (124838).
557
Lu S
et al.
Genome-wide association studies-derived susceptibility loci in type 2 diabetes: confirmation in a Chinese population.
Clin Invest Med,
2012
, 35 (E327).
558
Hoekstra M
et al.
Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias.
Front Physiol,
2012
, 3 (346).
559
Stump MR
et al.
Isoform-specific dominant-negative effects associated with hERG1 G628S mutation in long QT syndrome.
PLoS ONE,
2012
, 7 (e42552).
560
Krueger C
et al.
Pairing of homologous regions in the mouse genome is associated with transcription but not imprinting status.
PLoS ONE,
2012
, 7 (e38983).
561
Henrion U
et al.
Overlapping cardiac phenotype associated with a familial mutation in the voltage sensor of the KCNQ1 channel.
Cell. Physiol. Biochem.,
2012
, 29 (809-18).
562
Chen ZY
et al.
Structural and functional diversity of acidic scorpion potassium channel toxins.
PLoS ONE,
2012
, 7 (e35154).
563
Chen XD
et al.
Several polymorphisms of KCNQ1 gene are associated with plasma lipid levels in general Chinese populations.
PLoS ONE,
2012
, 7 (e34229).
564
Sato A
et al.
Long QT syndrome with nocturnal cardiac events caused by a KCNH2 missense mutation (G604S).
Intern. Med.,
2012
, 51 (1857-60).
565
Wang Y
et al.
Trafficking-deficient G572R-hERG and E637K-hERG activate stress and clearance pathways in endoplasmic reticulum.
PLoS ONE,
2012
, 7 (e29885).
566
Choveau FS
et al.
Opposite Effects of the S4-S5 Linker and PIP(2) on Voltage-Gated Channel Function: KCNQ1/KCNE1 and Other Channels.
,
2012
, 3 (125).
567
van Vliet-Ostaptchouk JV
et al.
Common variants in the type 2 diabetes KCNQ1 gene are associated with impairments in insulin secretion during hyperglycaemic glucose clamp.
PLoS ONE,
2012
, 7 (e32148).
568
Guo X
et al.
IKs protects from ventricular arrhythmia during cardiac ischemia and reperfusion in rabbits by preserving the repolarization reserve.
PLoS ONE,
2012
, 7 (e31545).
569
Olesen MS
et al.
Mutations in the potassium channel subunit KCNE1 are associated with early-onset familial atrial fibrillation.
BMC Med. Genet.,
2012
, 13 (24).
570
Yang XF
et al.
The antibody targeting the e314 Peptide of human kv1.3 pore region serves as a novel, potent and specific channel blocker.
PLoS ONE,
2012
, 7 (e36379).
571
Morris LM
et al.
Mouse middle ear ion homeostasis channels and intercellular junctions.
PLoS ONE,
2012
, 7 (e39004).
572
Liu Z
et al.
Update on the slow delayed rectifier potassium current (I(Ks)): role in modulating cardiac function.
Curr. Med. Chem.,
2012
, 19 (1405-20).
573
Harley CA
et al.
Changes in channel trafficking and protein stability caused by LQT2 mutations in the PAS domain of the HERG channel.
PLoS ONE,
2012
, 7 (e32654).
574
Ferro F
et al.
Long-chain acylcarnitines regulate the hERG channel.
PLoS ONE,
2012
, 7 (e41686).
575
Moric-Janiszewska E
et al.
Molecular diagnostics of families with long-QT syndrome.
Cardiol J,
2012
, 19 (159-67).
576
Robbins KM
et al.
Expression of KCNQ1OT1, CDKN1C, H19, and PLAGL1 and the methylation patterns at the KvDMR1 and H19/IGF2 imprinting control regions is conserved between human and bovine.
J. Biomed. Sci.,
2012
, 19 (95).
577
Sun Q
et al.
The association between KCNQ1 gene polymorphism and type 2 diabetes risk: a meta-analysis.
PLoS ONE,
2012
, 7 (e48578).
578
Adalsteinsson BT
et al.
Heterogeneity in white blood cells has potential to confound DNA methylation measurements.
PLoS ONE,
2012
, 7 (e46705).
579
Zheng Y
et al.
Hexachlorophene is a potent KCNQ1/KCNE1 potassium channel activator which rescues LQTs mutants.
PLoS ONE,
2012
, 7 (e51820).
580
Sato A
et al.
Benign premature ventricular complexes from the right ventricular outflow tract triggered polymorphic ventricular tachycardia in a latent type 2 LQTS patient.
Intern. Med.,
2012
, 51 (3261-5).
581
Kansara B
et al.
Placement of an implantable cardioverter-defibrillator in an infant with congenital long QT syndrome: Anesthetic considerations.
Ann Card Anaesth,
2011 May-Aug
, 14 (122-6).
582
Patoine D
et al.
A novel KCNQ1 variant (L203P) associated with torsades de pointes-related syncope in a Steinert syndrome patient.
Can J Cardiol,
2011 Mar-Apr
, 27 (263.e5-12).
583
Dennis AT
et al.
Antidepressant-induced ubiquitination and degradation of the cardiac potassium channel hERG.
J. Biol. Chem.,
2011
Sep
30
, 286 (34413-25).
584
Malan D
et al.
Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro.
Circ. Res.,
2011
Sep
30
, 109 (841-7).
585
Nakajo K
et al.
Nano-environmental changes by KCNE proteins modify KCNQ channel function.
,
2011
Sep
1
, 5 ().
586
Marangoni S
et al.
A Brugada syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization.
Cardiovasc. Res.,
2011
Sep
1
, 91 (606-16).
587
Liu CT
et al.
Genetic association for renal traits among participants of African ancestry reveals new loci for renal function.
PLoS Genet.,
2011
Sep
, 7 (e1002264).
588
Mani BK
et al.
Activation of vascular KCNQ (Kv7) potassium channels reverses spasmogen-induced constrictor responses in rat basilar artery.
Br. J. Pharmacol.,
2011
Sep
, 164 (237-49).
589
Digby GC
et al.
Acquired long QT interval: a case series of multifactorial QT prolongation.
Clin Cardiol,
2011
Sep
, 34 (577-82).
590
Mistry HD
et al.
Novel expression and regulation of voltage-dependent potassium channels in placentas from women with preeclampsia.
Hypertension,
2011
Sep
, 58 (497-504).
591
Golding MC
et al.
Depletion of Kcnq1ot1 non-coding RNA does not affect imprinting maintenance in stem cells.
Development,
2011
Sep
, 138 (3667-78).
592
Guo J
et al.
Interaction between the cardiac rapidly (IKr) and slowly (IKs) activating delayed rectifier potassium channels revealed by low K+-induced hERG endocytic degradation.
J. Biol. Chem.,
2011
Oct
7
, 286 (34664-74).
593
Cheng J
et al.
LQTS-associated mutation A257G in α1-syntrophin interacts with the intragenic variant P74L to modify its biophysical phenotype.
Cardiogenetics,
2011
Oct
25
, 1 ().
594
Wang K
et al.
Biophysical properties of slow potassium channels in human embryonic stem cell derived cardiomyocytes implicate subunit stoichiometry.
,
2011
Oct
24
, ().
595
Saba S
et al.
Cardiac Levels of NOS1AP RNA from Right Ventricular Tissue Recovered During Lead Extraction.
,
2011
Oct
18
, ().
596
Schwoerer AP
et al.
Bupivacaine Destabilizes Action Potential Duration in Cellular and Computational Models of Long QT Syndrome 1.
,
2011
Oct
14
, ().
597
Palmer BR
et al.
KCNE5 Polymorphism rs697829 is Associated with QT Interval and Survival in Acute Coronary Syndromes Patients.
,
2011
Oct
10
, ().
598
Lemoine MD
et al.
Arrhythmogenic left atrial cellular electrophysiology in a murine genetic long QT syndrome model.
Cardiovasc. Res.,
2011
Oct
1
, 92 (67-74).
599
Barsheshet A
et al.
Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation.
Circ Cardiovasc Genet,
2011
Oct
, 4 (491-9).
600
Kanda VA
et al.
Protein kinase C downregulates I(Ks) by stimulating KCNQ1-KCNE1 potassium channel endocytosis.
Heart Rhythm,
2011
Oct
, 8 (1641-7).
601
Migdalovich D
et al.
Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome.
Heart Rhythm,
2011
Oct
, 8 (1537-43).
602
Urashima T
et al.
Enhancing effects of salicylate on quinidine-induced block of human wild type and LQT3 related mutant cardiac Na+ channels.
Biomed. Res.,
2011
Oct
, 32 (303-12).
603
Nof E
et al.
LQT5 masquerading as LQT2: a dominant negative effect of KCNE1-D85N rare polymorphism on KCNH2 current.
Europace,
2011
Oct
, 13 (1478-83).
604
Garg V
et al.
Molecular determinants for activation of human ether-à-go-go-related gene 1 potassium channels by 3-nitro-n-(4-phenoxyphenyl) benzamide.
Mol. Pharmacol.,
2011
Oct
, 80 (630-7).
605
Bonaldi A
et al.
Microduplication of the ICR2 domain at chromosome 11p15 and familial Silver-Russell syndrome.
Am. J. Med. Genet. A,
2011
Oct
, 155A (2479-83).
606
Tester DJ
et al.
Unexplained drownings and the cardiac channelopathies: a molecular autopsy series.
Mayo Clin. Proc.,
2011
Oct
, 86 (941-7).
607
Calloe K
et al.
Multiple arrhythmic syndromes in a newborn, owing to a novel mutation in SCN5A.
Can. J. Physiol. Pharmacol.,
2011
Oct
, 89 (723-36).
608
Kilinc OU
et al.
Successful Elimination of Significant Arrhythmia Burden with Flecainide in an Adolescent with Long QT Syndrome Type 3.
,
2011
Nov
30
, ().
609
Lahti AL
et al.
Human disease model for long QT syndrome type 2 using iPS cells demonstrates arrhythmogenic characteristics in cell culture.
,
2011
Nov
3
, ().
610
Aoki Y
et al.
Role of ion channels in sepsis-induced atrial tachyarrhythmias in guinea pigs.
,
2011
Nov
3
, ().
611
Kääb S
et al.
A Large Candidate Gene Survey Identifies the KCNE1 D85N Polymorphism as a Possible Modulator of Drug-Induced Torsades de Pointes.
,
2011
Nov
18
, ().
612
Alzamora R
et al.
Sexual dimorphism and oestrogen regulation of KCNE3 expression modulates the functional properties of KCNQ1 K⁺ channels.
J. Physiol. (Lond.),
2011
Nov
1
, 589 (5091-107).
613
Zhang X
et al.
KCNQ5/K(v)7.5 potassium channel expression and subcellular localization in primate retinal pigment epithelium and neural retina.
Am. J. Physiol., Cell Physiol.,
2011
Nov
, 301 (C1017-26).
614
Bai YL
et al.
HIV Tat protein inhibits hERG K+ channels: a potential mechanism of HIV infection induced LQTs.
J. Mol. Cell. Cardiol.,
2011
Nov
, 51 (876-80).
615
Saif-Ali R
et al.
KCNQ1 variants associate with type 2 diabetes in Malaysian Malay subjects.
Ann. Acad. Med. Singap.,
2011
Nov
, 40 (488-92).
616
Parvez B
et al.
The "missing" link in atrial fibrillation heritability.
J Electrocardiol,
2011
Nov
, 44 (641-4).
617
Kaufman ES
Arrhythmic risk in congenital long QT syndrome.
J Electrocardiol,
2011
Nov
, 44 (645-9).
618
Tsuji-Wakisaka K
et al.
Identification and functional characterization of KCNQ1 mutations around the exon 7-intron 7 junction affecting the splicing process.
Biochim. Biophys. Acta,
2011
Nov
, 1812 (1452-9).
619
Nakajo K
et al.
KCNQ1 subdomains involved in KCNE modulation revealed by an invertebrate KCNQ1 orthologue.
J. Gen. Physiol.,
2011
Nov
, 138 (521-35).
620
Lobarinas E
et al.
Effects of the potassium ion channel modulators BMS-204352 Maxipost and its R-enantiomer on salicylate-induced tinnitus in rats.
,
2011
May
27
, ().
621
Li Y
et al.
KCNE1 enhances phosphatidylinositol 4,5-bisphosphate (PIP2) sensitivity of IKs to modulate channel activity.
,
2011
May
16
, ().
622
Du X
et al.
Characteristics and molecular basis of celecoxib modulation on Kv7 potassium channels.
,
2011
May
13
, ().
623
Yanni J
et al.
Changes in Ion Channel Gene Expression Underlying Heart Failure-induced Sinoatrial Node Dysfunction.
,
2011
May
12
, ().
624
Ando F
et al.
Synergic effects of β-estradiol and erythromycin on hERG currents.
J. Membr. Biol.,
2011
May
, 241 (31-8).
625
Tavira B
et al.
KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients.
Clin Transplant,
2011
May
, 25 (E284-91).
626
Horne AJ
et al.
A novel mechanism for LQT3 with 2:1 block: a pore-lining mutation in Nav1.5 significantly affects voltage-dependence of activation.
Heart Rhythm,
2011
May
, 8 (770-7).
627
Soma K
et al.
Abundant expression of KCNE1 in the left ventricle of the miniature pig.
Heart Vessels,
2011
May
, 26 (353-6).
628
Al-Khtib M
et al.
Vitrification at the germinal vesicle stage does not affect the methylation profile of H19 and KCNQ1OT1 imprinting centers in human oocytes subsequently matured in vitro.
Fertil. Steril.,
2011
May
, 95 (1955-60).
629
Guo J
et al.
Involvement of caveolin in probucol-induced reduction in hERG plasma-membrane expression.
Mol. Pharmacol.,
2011
May
, 79 (806-13).
630
Haapalahti P
et al.
Comparison of QT peak and QT end interval responses to autonomic adaptation in asymptomatic LQT1 mutation carriers.
Clin Physiol Funct Imaging,
2011
May
, 31 (209-14).
631
Nielsen T
et al.
Type 2 diabetes risk allele near CENTD2 is associated with decreased glucose-stimulated insulin release.
Diabetologia,
2011
May
, 54 (1052-6).
632
Jespersen T
Regulation and physiological function of Na(v) 1.5 and KCNQ1 channels.
Acta Physiol (Oxf),
2011
May
, 202 Suppl 683 (1-26).
633
Schwartz PJ
Pharmacological and Non-Pharmacological Management of the Congenital Long QT Syndrome: The Rationale.
,
2011
Mar
9
, ().
634
Ouillé A
et al.
ION CHANNEL BLOCKING PROFILE OF COMPOUNDS WITH REPORTED TORSADOGENIC EFFECTS: WHAT CAN BE LEARNED?
,
2011
Mar
8
, ().
635
Jons C
et al.
Use of Mutant-Specific Ion Channel Characteristics for Risk Stratification of Long QT Syndrome Patients.
Sci Transl Med,
2011
Mar
30
, 3 (76ra28).
636
Zhang T
et al.
LQTS mutation N1325S in cardiac sodium channel gene SCN5A causes cardiomyocyte apoptosis, cardiac fibrosis and contractile dysfunction in mice.
Int. J. Cardiol.,
2011
Mar
3
, 147 (239-45).
637
Wu D
et al.
Traditional Chinese formula, lubricating gut pill, stimulates cAMP-dependent CI(−) secretion across rat distal colonic mucosa.
J Ethnopharmacol,
2011
Mar
24
, 134 (406-13).
638
Song P
et al.
Kir4.1 channel expression is essential for parietal cell control of acid secretion.
,
2011
Mar
2
, ().
639
Matsa E
et al.
Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation.
,
2011
Mar
2
, ().
640
Novotny T
et al.
Mutation Analysis Ion Channel Genes Ventricular Fibrillation Survivors with Coronary Artery Disease.
,
2011
Mar
16
, ().
641
Yazawa M
et al.
Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome.
Nature,
2011
Mar
10
, 471 (230-4).
642
Papatheodoropoulos C
et al.
α5GABAA receptors regulate hippocampal sharp wave-ripple activity in vitro.
Neuropharmacology,
2011
Mar
, 60 (662-73).
643
Yu W
et al.
Effects of KCNQ1 polymorphisms on the therapeutic efficacy of oral antidiabetic drugs in Chinese patients with type 2 diabetes.
Clin. Pharmacol. Ther.,
2011
Mar
, 89 (437-42).
644
Skinner JR
et al.
Prospective, population-based long QT molecular autopsy study of postmortem negative sudden death in 1 to 40 year olds.
Heart Rhythm,
2011
Mar
, 8 (412-9).
645
Amorós I
et al.
Functional effects of a missense mutation in HERG associated with type 2 long QT syndrome.
Heart Rhythm,
2011
Mar
, 8 (463-70).
646
Kim Y
et al.
Suppression of CFTR-mediated Cl secretion of airway epithelium in vitamin C-deficient mice.
J. Korean Med. Sci.,
2011
Mar
, 26 (317-24).
647
Vangipurapu J
et al.
Association of indices of liver and adipocyte insulin resistance with 19 confirmed susceptibility loci for type 2 diabetes in 6,733 non-diabetic Finnish men.
Diabetologia,
2011
Mar
, 54 (563-71).
648
Gianulis EC
et al.
Rescue of aberrant gating by a genetically encoded PAS (Per-Arnt-Sim) domain in several long QT syndrome mutant human ether-á-go-go-related gene potassium channels.
J. Biol. Chem.,
2011
Jun
24
, 286 (22160-9).
649
Cheng EP
et al.
Restoration of Normal L-Type Ca2+ Channel Function During Timothy Syndrome by Ablation of an Anchoring Protein.
,
2011
Jun
23
, ().
650
Buber J
et al.
Risk of recurrent cardiac events after onset of menopause in women with congenital long-QT syndrome types 1 and 2.
Circulation,
2011
Jun
21
, 123 (2784-91).
651
Sroubek J
et al.
Protein kinase A activity at the endoplasmic reticulum surface is responsible for augmentation of human ether-a-go-go-related gene product (HERG).
J. Biol. Chem.,
2011
Jun
17
, 286 (21927-36).
652
Park KS
et al.
Identification and functional characterization of ion channels in CD34(+) hematopoietic stem cells from human peripheral blood.
,
2011
Jun
1
, ().
653
Mo J
et al.
Altered gene expression by low-dose arsenic exposure in humans and cultured cardiomyocytes: assessment by real-time PCR arrays.
Int J Environ Res Public Health,
2011
Jun
, 8 (2090-108).
654
Kanduri C
Kcnq1ot1: a chromatin regulatory RNA.
Semin. Cell Dev. Biol.,
2011
Jun
, 22 (343-50).
655
Vigneault P
et al.
Prolongation of cardiac ventricular repolarization under paliperidone: how and how much?
J. Cardiovasc. Pharmacol.,
2011
Jun
, 57 (690-5).
656
Rees SD
et al.
Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations.
Diabetologia,
2011
Jun
, 54 (1368-74).
657
Rodriguez BA
et al.
Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells.
Carcinogenesis,
2011
Jun
, 32 (812-21).
658
Zhou PZ
et al.
Activation of human ether-a-go-go related gene (hERG) potassium channels by small molecules.
Acta Pharmacol. Sin.,
2011
Jun
, 32 (781-8).
659
Obata Y
et al.
Epigenetically immature oocytes lead to loss of imprinting during embryogenesis.
J. Reprod. Dev.,
2011
Jun
, 57 (327-34).
660
Neal AM
et al.
Renal defects in KCNE1 knockout mice are mimicked by chromanol 293B in vivo: identification of a KCNE1-regulated K+ conductance in the proximal tubule.
J. Physiol. (Lond.),
2011
Jul
15
, 589 (3595-609).
661
Tveito A
et al.
Defining candidate drug characteristics for Long-QT (LQT3) syndrome.
Math Biosci Eng,
2011
Jul
, 8 (861-73).
662
Allegue C
et al.
Prevalence of HCM and long QT syndrome mutations in young sudden cardiac death-related cases.
Int. J. Legal Med.,
2011
Jul
, 125 (565-72).
663
Jones MJ
et al.
An extended domain of Kcnq1ot1 silencing revealed by an imprinted fluorescent reporter.
Mol. Cell. Biol.,
2011
Jul
, 31 (2827-37).
664
Schroner Z
et al.
Variation in KCNQ1 is associated with therapeutic response to sulphonylureas.
Med. Sci. Monit.,
2011
Jul
, 17 (CR392-6).
665
Hassinen M
et al.
Thermal adaptation of the crucian carp (Carassius carassius) cardiac delayed rectifier current, IKs, by homomeric assembly of Kv7.1 subunits without MinK.
Am. J. Physiol. Regul. Integr. Comp. Physiol.,
2011
Jul
, 301 (R255-65).
666
Smith JL
et al.
Trafficking-deficient hERG K⁺ channels linked to long QT syndrome are regulated by a microtubule-dependent quality control compartment in the ER.
Am. J. Physiol., Cell Physiol.,
2011
Jul
, 301 (C75-85).
667
Couderc JP
et al.
T-wave morphology abnormalities in benign, potent, and arrhythmogenic I(kr) inhibition.
Heart Rhythm,
2011
Jul
, 8 (1036-43).
668
Wang RR
et al.
Novel compound heterozygous mutations T2C and 1149insT in the KCNQ1 gene cause Jervell and Lange-Nielsen syndrome.
Int. J. Mol. Med.,
2011
Jul
, 28 (41-6).
669
Li X
et al.
Bisoprolol reverses down-regulation of potassium channel proteins in ventricular tissues of rabbits with heart failure.
J Biomed Res,
2011
Jul
, 25 (274-279).
670
Choveau FS
et al.
KCNQ1 channels voltage dependence through a voltage-dependent binding of the S4-S5 linker to the pore domain.
J. Biol. Chem.,
2011
Jan
7
, 286 (707-16).
671
Labro AJ
et al.
The S4-S5 linker of KCNQ1 channels forms a structural scaffold with the S6 segment controlling gate closure.
J. Biol. Chem.,
2011
Jan
7
, 286 (717-25).
672
Barc J
et al.
Screening for copy number variation in genes associated with the long QT syndrome: clinical relevance.
J. Am. Coll. Cardiol.,
2011
Jan
4
, 57 (40-7).
673
Peal DS
et al.
Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen.
Circulation,
2011
Jan
4
, 123 (23-30).
674
Abd Allah E
et al.
Changes in the expression of ion channels, connexins and Ca2+ handling proteins in the sinoatrial node during postnatal development.
,
2011
Jan
28
, ().
675
Thomas AM
et al.
Characterization of a binding site for anionic phospholipids on KCNQ1.
J. Biol. Chem.,
2011
Jan
21
, 286 (2088-100).
676
Kauferstein S
et al.
A novel mutation in the cardiac ryanodine receptor gene (RyR2) in a patient with an unequivocal LQTS.
Int. J. Cardiol.,
2011
Jan
21
, 146 (249-50).
677
Obiol-Pardo C
et al.
A Multiscale Simulation System for the Prediction of Drug-Induced Cardiotoxicity.
,
2011
Jan
20
, ().
678
Itzhaki I
et al.
Modelling the long QT syndrome with induced pluripotent stem cells.
,
2011
Jan
16
, ().
679
Aidery P
et al.
Biophysical properties of mutant KCNQ1 S277L channels linked to hereditary long QT syndrome with phenotypic variability.
,
2011
Jan
15
, ().
680
Millat G
et al.
Development of a high resolution melting method for the detection of genetic variations in Long QT Syndrome.
Clin. Chim. Acta,
2011
Jan
14
, 412 (203-7).
681
Han S
et al.
Fluconazole inhibits hERG K(+) channel by direct block and disruption of protein trafficking.
Eur. J. Pharmacol.,
2011
Jan
10
, 650 (138-44).
682
Stump MR
et al.
Multiple splicing defects caused by hERG splice site mutation 2592+1G>A associated with long QT syndrome.
Am. J. Physiol. Heart Circ. Physiol.,
2011
Jan
, 300 (H312-8).
683
Gong Q
et al.
Inhibition of nonsense-mediated mRNA decay by antisense morpholino oligonucleotides restores functional expression of hERG nonsense and frameshift mutations in long-QT syndrome.
J. Mol. Cell. Cardiol.,
2011
Jan
, 50 (223-9).
684
Huang H
et al.
Y1767C, a novel SCN5A mutation, induces a persistent Na+ current and potentiates ranolazine inhibition of Nav1.5 channels.
Am. J. Physiol. Heart Circ. Physiol.,
2011
Jan
, 300 (H288-99).
685
Parkman HP
et al.
Domperidone treatment for gastroparesis: demographic and pharmacogenetic characterization of clinical efficacy and side-effects.
Dig. Dis. Sci.,
2011
Jan
, 56 (115-24).
686
Viadero MT
et al.
Three generations of hereditary long-QT syndrome with complete penetrance caused by the p.G316E KCNQ1 mutation.
Pediatr Cardiol,
2011
Jan
, 32 (102-4).
687
Bartos DC
et al.
R231C mutation in KCNQ1 causes long QT syndrome type 1 and familial atrial fibrillation.
Heart Rhythm,
2011
Jan
, 8 (48-55).
688
Fröhlich H
et al.
Hypothyroidism of gene-targeted mice lacking Kcnq1.
Pflugers Arch.,
2011
Jan
, 461 (45-52).
689
Ernesto C
et al.
[Investigation of ion channel gene variants in patients with long QT syndrome.]
,
2011
Feb
4
, ().
690
Durdagi S
et al.
Combined receptor and ligand-based approach to the universal pharmacophore model development for studies of drug blockade to the hERG1 pore domain.
J Chem Inf Model,
2011
Feb
28
, 51 (463-74).
691
Nathan AT
et al.
Implications of Anesthesia in Children with Long QT Syndrome.
,
2011
Feb
23
, ().
692
Li P
et al.
Reciprocal control of hERG stability by Hsp70 and Hsc70 with implication for restoration of LQT2 mutant stability.
Circ. Res.,
2011
Feb
18
, 108 (458-68).
693
Ma LJ
et al.
Allosteric Features of KCNQ1 Gating Revealed by Alanine Scanning Mutagenesis.
Biophys. J.,
2011
Feb
16
, 100 (885-94).
694
Ciampa EJ
et al.
KCNE4 juxtamembrane region is required for interaction with calmodulin and for functional suppression of KCNQ1.
J. Biol. Chem.,
2011
Feb
11
, 286 (4141-9).
695
Dobríková M
et al.
[Relationship of the CDKAL1 and KCNQ1 gene polymorphisms to the age at diagnosis of type 2 diabetes in the Slovakian population].
Vnitr Lek,
2011
Feb
, 57 (155-8).
696
Alesutan I
et al.
Inhibition of the heterotetrameric K+ channel KCNQ1/KCNE1 by the AMP-activated protein kinase.
Mol. Membr. Biol.,
2011
Feb
, 28 (79-89).
697
Roepke TK
et al.
Genetic dissection reveals unexpected influence of beta subunits on KCNQ1 K+ channel polarized trafficking in vivo.
FASEB J.,
2011
Feb
, 25 (727-36).
698
Bentzen BH
et al.
Pharmacological activation of Kv11.1 in transgenic long QT-1 rabbits.
J. Cardiovasc. Pharmacol.,
2011
Feb
, 57 (223-30).
699
Wang YH
et al.
Gating-related molecular motions in the extracellular domain of the IKs channel: implications for IKs channelopathy.
J. Membr. Biol.,
2011
Feb
, 239 (137-56).
700
Li JL
et al.
[Association of age-related hearing loss with ion transporter KCNQ1 and NKCC1 in cochlea of C57BL/6J mice].
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi,
2011
Feb
, 46 (139-43).
701
Davies MR
et al.
An In silico Canine Cardiac Midmyocardial Action Potential Duration Model as a Tool for Early Drug Safety Assessment.
,
2011
Dec
23
, ().
702
703
Coey AT
et al.
Reconstitution of KCNE1 into lipid bilayers: comparing the structural, dynamic, and activity differences in micelle and vesicle environments.
Biochemistry,
2011
Dec
20
, 50 (10851-9).
704
Yamazaki K
et al.
A novel method of selecting human embryonic stem cell-derived cardiomyocyte clusters for assessment of potential to influence QT interval.
,
2011
Dec
14
, ().
705
706
Sung RK
et al.
QTc prolongation and family history of sudden death in a patient with desmin cardiomyopathy.
Pacing Clin Electrophysiol,
2011
Dec
, 34 (e105-8).
707
Krause U
et al.
A rare association of long QT syndrome and syndactyly: Timothy syndrome (LQT 8).
Clin Res Cardiol,
2011
Dec
, 100 (1123-7).
708
Chen J
et al.
A dual mechanism for I(Ks) current reduction by the pathogenic mutation KCNQ1-S277L.
Pacing Clin Electrophysiol,
2011
Dec
, 34 (1652-64).
709
Maillé E
et al.
Regulation of normal and cystic fibrosis airway epithelial repair processes by TNF-α after injury.
Am. J. Physiol. Lung Cell Mol. Physiol.,
2011
Dec
, 301 (L945-55).
710
Mikuni I
et al.
Partial restoration of the long QT syndrome associated KCNQ1 A341V mutant by the KCNE1 β-subunit.
Biochim. Biophys. Acta,
2011
Dec
, 1810 (1285-93).
711
Trudeau MC
et al.
hERG1a N-terminal eag domain-containing polypeptides regulate homomeric hERG1b and heteromeric hERG1a/hERG1b channels: a possible mechanism for long QT syndrome.
J. Gen. Physiol.,
2011
Dec
, 138 (581-92).
712
Aziz PF
et al.
Genotype- and mutation site-specific QT adaptation during exercise, recovery, and postural changes in children with long-QT syndrome.
Circ Arrhythm Electrophysiol,
2011
Dec
, 4 (867-73).
713
Roepke TK
et al.
KCNE2 forms potassium channels with KCNA3 and KCNQ1 in the choroid plexus epithelium.
FASEB J.,
2011
Dec
, 25 (4264-73).
714
Shao C
et al.
Electrophysiological study of V535M hERG mutation of LQT2.
J. Huazhong Univ. Sci. Technol. Med. Sci.,
2011
Dec
, 31 (741-8).
715
Goldenberg I
et al.
Trigger-specific ion-channel mechanisms, risk factors, and response to therapy in type 1 long QT syndrome.
,
2011
Aug
24
, ().
716
Larsen AP
et al.
Extracellular potassium inhibits Kv7.1 potassium channels by stabilizing an inactivated state.
Biophys. J.,
2011
Aug
17
, 101 (818-27).
717
Alzamora R
et al.
Estrogen inhibits chloride secretion caused by cholera and Escherichia coli enterotoxins in female rat distal colon.
Steroids,
2011
Aug
, 76 (867-76).
718
Lin S
et al.
Nonallelic transcriptional roles of CTCF and cohesins at imprinted loci.
Mol. Cell. Biol.,
2011
Aug
, 31 (3094-104).
719
Fougere RR
et al.
Functional characterization of the LQT2-causing mutation R582C and the associated voltage-dependent fluorescence signal.
Heart Rhythm,
2011
Aug
, 8 (1273-80).
720
Zarraga IG
et al.
Nonsense-mediated mRNA decay caused by a frameshift mutation in a large kindred of type 2 long QT syndrome.
Heart Rhythm,
2011
Aug
, 8 (1200-6).
721
Takahara A
et al.
Measurements of Cardiac Ion Channel Subunits in the Chronic Atrioventricular Block Dog.
,
2011
Apr
21
, ().
722
Horigome H
et al.
Detection of Extra-Components of T Wave by Independent Component Analysis in Congenital Long QT Syndrome.
,
2011
Apr
21
, ().
723
Yamagata K
et al.
Voltage-gated K+ channel KCNQ1 regulates insulin secretion in MIN6 β-cell line.
Biochem. Biophys. Res. Commun.,
2011
Apr
15
, 407 (620-5).
724
Ohno S
et al.
KCNE5 (KCNE1L) Variants Are Novel Modulator of Brugada Syndrome and Idiopathic Ventricular Fibrillation.
,
2011
Apr
14
, ().
725
Albesa M
et al.
Nedd4-2 dependent ubiquitylation and regulation of the cardiac potassium channel hERG.
,
2011
Apr
1
, ().
726
El Gebeily G
et al.
Upregulation of ventricular potassium channels by chronic tamoxifen treatment.
Cardiovasc. Res.,
2011
Apr
1
, 90 (68-76).
727
Hekkala AM
et al.
Epinephrine bolus test in detecting long QT syndrome mutation carriers with indeterminable electrocardiographic phenotype.
Ann Noninvasive Electrocardiol,
2011
Apr
, 16 (172-9).
728
Grilo LS
et al.
Patient with syncope and LQTS carrying a mutation in the PAS domain of the hERG1 channel.
Ann Noninvasive Electrocardiol,
2011
Apr
, 16 (213-8).
729
Van Horn WD
et al.
Working model for the structural basis for KCNE1 modulation of the KCNQ1 potassium channel.
Curr. Opin. Struct. Biol.,
2011
Apr
, 21 (283-91).
730
Cooper EC
Made for "anchorin": Kv7.2/7.3 (KCNQ2/KCNQ3) channels and the modulation of neuronal excitability in vertebrate axons.
Semin. Cell Dev. Biol.,
2011
Apr
, 22 (185-92).
731
Winbo A
et al.
Origin of the Swedish long QT syndrome Y111C/KCNQ1 founder mutation.
Heart Rhythm,
2011
Apr
, 8 (541-7).
732
Andersen MN
et al.
Kv7.1 surface expression is regulated by epithelial cell polarization.
Am. J. Physiol., Cell Physiol.,
2011
Apr
, 300 (C814-24).
733
Rice KS
et al.
Elevated serum gastrin levels in Jervell and Lange-Nielsen syndrome: a marker of severe KCNQ1 dysfunction?
Heart Rhythm,
2011
Apr
, 8 (551-4).
734
Moric Janiszewska E
et al.
Expression of genes KCNQ1 and HERG encoding potassium ion channels Ik(r), Ik(s) in long QT syndrome.
Kardiol Pol,
2011
, 69 (423-9).
735
Alzamora R
et al.
Berberine Reduces cAMP-Induced Chloride Secretion in T84 Human Colonic Carcinoma Cells through Inhibition of Basolateral KCNQ1 Channels.
Front Physiol,
2011
, 2 (33).
736
Walzik S
et al.
Alternative splicing of the cardiac sodium channel creates multiple variants of mutant T1620K channels.
PLoS ONE,
2011
, 6 (e19188).
737
Frolov RV
et al.
Inhibition of HERG potassium channels by celecoxib and its mechanism.
PLoS ONE,
2011
, 6 (e26344).
738
Rotte A
et al.
Ca2+ activated K+ channel Kca3.1 as a determinant of gastric acid secretion.
Cell. Physiol. Biochem.,
2011
, 27 (597-604).
739
Strutz-Seebohm N
et al.
Structural basis of slow activation gating in the cardiac I Ks channel complex.
Cell. Physiol. Biochem.,
2011
, 27 (443-52).
741
Mihic A
et al.
Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long QT syndrome mutation.
PLoS ONE,
2011
, 6 (e18273).
742
Liu X
et al.
ENU mutagenesis screen to establish motor phenotypes in wild-type mice and modifiers of a pre-existing motor phenotype in tau mutant mice.
J. Biomed. Biotechnol.,
2011
, 2011 (130947).
743
Algar E
et al.
An 11p15 imprinting centre region 2 deletion in a family with Beckwith Wiedemann syndrome provides insights into imprinting control at CDKN1C.
PLoS ONE,
2011
, 6 (e29034).
744
Cavaliere S
et al.
Drosophila KCNQ channel displays evolutionarily conserved electrophysiology and pharmacology with mammalian KCNQ channels.
PLoS ONE,
2011
, 6 (e23898).
745
Yun J
et al.
Hirsutenone directly blocks human ether-a-go-go related gene K+ channels.
Biol. Pharm. Bull.,
2011
, 34 (1815-22).
746
Girmatsion Z
et al.
N-terminal arginines modulate plasma-membrane localization of Kv7.1/KCNE1 channel complexes.
PLoS ONE,
2011
, 6 (e26967).
747
Saif-Ali R
et al.
KCNQ1 haplotypes associate with type 2 diabetes in Malaysian Chinese Subjects.
Int J Mol Sci,
2011
, 12 (5705-18).
748
Been LF
et al.
Variants in KCNQ1 increase type II diabetes susceptibility in South Asians: a study of 3,310 subjects from India and the US.
BMC Med. Genet.,
2011
, 12 (18).
749
Namekata I
et al.
Blocking effect of NIP-142 on the KCNQ1/KCNE1 channel current expressed in HEK293 cells.
Biol. Pharm. Bull.,
2011
, 34 (153-5).
750
Nekouzadeh A
et al.
Continuum Molecular Simulation of Large Conformational Changes during Ion-Channel Gating.
PLoS ONE,
2011
, 6 (e20186).
751
Lahtinen AM
et al.
KCNE1 D85N polymorphism - a sex-specific modifier in type 1 long QT syndrome?
BMC Med. Genet.,
2011
, 12 (11).
752
Couderc JP
et al.
Short and long QT syndromes: does QT length really matter?
J Electrocardiol,
2010 Sep-Oct
, 43 (396-9).
753
Lang F
et al.
SGK, renal function and hypertension.
J. Nephrol.,
2010 Nov-Dec
, 23 Suppl 16 (S124-9).
754
Cirović S
et al.
Differential expression of KCNQ1 K+ channel in tubular cells of frog kidney.
Eur J Histochem,
2010 Jan-Mar
, 54 (e7).
755
Shah DP
et al.
Ranolazine Safely Decreases Ventricular and Atrial Fibrillation in Timothy Syndrome (LQT8).
,
2010
Sep
30
, ().
756
Alzamora R
et al.
AMP-Activated Protein Kinase Inhibits KCNQ1 Channels Through Regulation of the Ubiquitin Ligase Nedd4-2 in Renal Epithelial Cells.
,
2010
Sep
22
, ().
757
Haugaa KH
et al.
Transmural Differences in Myocardial Contraction in Long-QT Syndrome. Mechanical Consequences of Ion Channel Dysfunction.
,
2010
Sep
20
, ().
758
Piron J
et al.
KCNE1-KCNQ1 osmoregulation by interaction of phosphatidylinositol-4,5-bisphosphate with Mg2+ and polyamines.
J. Physiol. (Lond.),
2010
Sep
15
, 588 (3471-83).
759
Ng FL
et al.
Expression and function of the K(+) channel KCNQ genes in human arteries.
,
2010
Sep
14
, ().
760
Ren XQ
et al.
Pore Mutants of HERG and KvLQT1 Downregulate the Reciprocal Currents in Stable Cell Lines.
,
2010
Sep
10
, ().
761
Zhong XZ
et al.
Participation of KCNQ (Kv7) potassium channels in myogenic control of cerebral arterial diameter.
J. Physiol. (Lond.),
2010
Sep
1
, 588 (3277-93).
762
Nanda Kumar NS
et al.
Mucosal potassium efflux mediated via Kcnn4 channels provides the driving force for electrogenic anion secretion in colon.
Am. J. Physiol. Gastrointest. Liver Physiol.,
2010
Sep
, 299 (G707-14).
763
Bokil NJ
et al.
Molecular genetics of long QT syndrome.
Mol. Genet. Metab.,
2010
Sep
, 101 (1-8).
764
Moretti A
et al.
Patient-specific induced pluripotent stem-cell models for long-QT syndrome.
N. Engl. J. Med.,
2010
Oct
7
, 363 (1397-409).
765
Nakajo K
et al.
Stoichiometry of the KCNQ1 - KCNE1 ion channel complex.
,
2010
Oct
20
, ().
766
Tester DJ
et al.
Prevalence and spectrum of large deletions or duplications in the major long QT syndrome-susceptibility genes and implications for long QT syndrome genetic testing.
Am. J. Cardiol.,
2010
Oct
15
, 106 (1124-8).
767
Lian J
et al.
Novel characteristics of a trafficking-defective G572R-hERG channel linked to hereditary long QT syndrome.
Can J Cardiol,
2010
Oct
, 26 (417-22).
768
Kuryshev YA
et al.
Increased cardiac risk in concomitant methadone and diazepam treatment: pharmacodynamic interactions in cardiac ion channels.
J. Cardiovasc. Pharmacol.,
2010
Oct
, 56 (420-30).
769
Furushima H
et al.
Fetal atrioventricular block and postpartum augmentative QT prolongation in a patient with long-QT syndrome with KCNQ1 mutation.
J. Cardiovasc. Electrophysiol.,
2010
Oct
, 21 (1170-3).
770
Dautova Y
et al.
Atrial arrhythmogenic properties in wild-type and Scn5a+/- murine hearts.
Exp. Physiol.,
2010
Oct
, 95 (994-1007).
771
Baek JS
et al.
Jervell and Lange-Nielsen syndrome: novel compound heterozygous mutations in the KCNQ1 in a Korean family.
J. Korean Med. Sci.,
2010
Oct
, 25 (1522-5).
772
Hammoud SS
et al.
Alterations in sperm DNA methylation patterns at imprinted loci in two classes of infertility.
Fertil. Steril.,
2010
Oct
, 94 (1728-33).
773
Oka Y
et al.
Atrioventricular block-induced Torsades de Pointes with clinical and molecular backgrounds similar to congenital long QT syndrome.
Circ. J.,
2010
Nov
25
, 74 (2562-71).
774
Subbotina J
et al.
Structural refinement of the hERG1 pore and voltage-sensing domains with ROSETTA-membrane and molecular dynamics simulations.
Proteins,
2010
Nov
1
, 78 (2922-34).
775
Sy RW
et al.
Repolarization dynamics during exercise discriminate between LQT1 and LQT2 genotypes.
J. Cardiovasc. Electrophysiol.,
2010
Nov
, 21 (1242-6).
776
Purtell K
et al.
Cardiac arrhythmia and thyroid dysfunction: a novel genetic link.
Int. J. Biochem. Cell Biol.,
2010
Nov
, 42 (1767-70).
779
Roura-Ferrer M
et al.
Impact of KCNE subunits on KCNQ1 (Kv7.1) channel membrane surface targeting.
J. Cell. Physiol.,
2010
Nov
, 225 (692-700).
780
Park JH
et al.
High expression of large-conductance Ca(2+)-activated K(+) channel in the CD133(+) subpopulation of SH-SY5Y neuroblastoma cells.
,
2010
May
7
, ().
781
Kang J
et al.
In Vitro Electrocardiographic and Cardiac Ion Channel Effects of (-)-Epigallocatechin-3-Gallate, the Main Catechin of Green Tea.
,
2010
May
18
, ().
782
Matsuzaki J
et al.
Acid Suppression by Proton Pump Inhibitors Enhances Aquaporin-4 and KCNQ1 Expression in Gastric Fundic Parietal Cells in Mouse.
,
2010
May
1
, ().
783
Eldstrom J
et al.
Mechanistic basis for LQT1 caused by S3 mutations in the KCNQ1 subunit of IKs.
J. Gen. Physiol.,
2010
May
, 135 (433-48).
784
Allegue C
et al.
A new approach to long QT syndrome mutation detection by Sequenom MassARRAY system.
Electrophoresis,
2010
May
, 31 (1648-55).
785
Dong MQ
et al.
Regulation of human cardiac KCNQ1/KCNE1 channel by epidermal growth factor receptor kinase.
Biochim. Biophys. Acta,
2010
May
, 1798 (995-1001).
786
Svendsen JH
et al.
Screening for, and management of, possible arrhythmogenic syndromes (channelopathies/ion channel diseases).
Europace,
2010
May
, 12 (741-2).
787
Navedo MF
et al.
Increased coupled gating of L-type Ca2+ channels during hypertension and Timothy syndrome.
Circ. Res.,
2010
Mar
5
, 106 (748-56).
788
Preston P
et al.
Disruption of the K+ channel beta-subunit KCNE3 reveals an important role in intestinal and tracheal Cl- transport.
J. Biol. Chem.,
2010
Mar
5
, 285 (7165-75).
789
Zheng R
et al.
Analysis of the interactions between the C-terminal cytoplasmic domains of KCNQ1 and KCNE1 channel subunits.
,
2010
Mar
2
, ().
790
Leong IU
et al.
Zebrafish as a model for Long QT syndrome: the evidence, and the means of manipulating zebrafish gene expression.
,
2010
Mar
19
, ().
792
Pan Q
et al.
KCNQ1 loss-of-function mutation impairs gastric acid secretion in mice.
Mol. Biol. Rep.,
2010
Mar
, 37 (1329-33).
793
Summers KM
et al.
Mutations at KCNQ1 and an unknown locus cause long QT syndrome in a large Australian family: implications for genetic testing.
Am. J. Med. Genet. A,
2010
Mar
, 152A (613-21).
794
Gray C
et al.
Expression of a common LQT1 mutation in five apparently unrelated families in a regional inherited arrhythmia clinic.
J. Cardiovasc. Electrophysiol.,
2010
Mar
, 21 (296-300).
795
Amin AS
et al.
Fever-triggered ventricular arrhythmias in Brugada syndrome and type 2 long-QT syndrome.
Neth Heart J,
2010
Mar
, 18 (165-9).
796
Fink M
et al.
Pharmacodynamic effects in the cardiovascular system: the modeller's view.
Basic Clin. Pharmacol. Toxicol.,
2010
Mar
, 106 (243-9).
797
Vanoye CG
et al.
KCNQ1/KCNE1 assembly, co-translation not required.
Channels (Austin),
2010
Mar
, 4 (108-14).
798
Itoh H
et al.
Long QT Syndrome with Compound Mutations is Associated with a More Severe Phenotype :A Japanese Multicenter Study.
,
2010
Jun
8
, ().
799
Lang F
et al.
Significance of SGK1 in the regulation of neuronal function.
,
2010
Jun
7
, ().
800
Yang Y
et al.
Identification of a Kir3.4 mutation in congenital long QT syndrome.
Am. J. Hum. Genet.,
2010
Jun
11
, 86 (872-80).
801
Valdivia CR
et al.
Loss-of-function mutation of the SCN3B-encoded sodium channel {beta}3 subunit associated with a case of idiopathic ventricular fibrillation.
Cardiovasc. Res.,
2010
Jun
1
, 86 (392-400).
802
Lvov A
et al.
Identification of a protein-protein interaction between KCNE1 and the activation gate machinery of KCNQ1.
J. Gen. Physiol.,
2010
Jun
, 135 (607-18).
803
Zhou JB
et al.
Variants in KCNQ1, AP3S1, MAN2A1, and ALDH7A1 and the risk of type 2 diabetes in the Chinese Northern Han population: a case-control study and meta-analysis.
Med. Sci. Monit.,
2010
Jun
, 16 (BR179-83).
804
Lin EC
et al.
Properties of WT and mutant hERG K(+) channels expressed in neonatal mouse cardiomyocytes.
Am. J. Physiol. Heart Circ. Physiol.,
2010
Jun
, 298 (H1842-9).
805
Wu D
et al.
State-dependent electrostatic interactions of S4 arginines with E1 in S2 during Kv7.1 activation.
J. Gen. Physiol.,
2010
Jun
, 135 (595-606).
806
Labro AJ
et al.
The rate-dependent biophysical properties of the LQT1 H258R mutant are counteracted by a dominant negative effect on channel trafficking.
J. Mol. Cell. Cardiol.,
2010
Jun
, 48 (1096-104).
807
808
809
810
Choi SH
et al.
Ginsenoside Rg3 activates human KCNQ1 K+ channel currents through interacting with the K318 and V319 residues: a role of KCNE1 subunit.
Eur. J. Pharmacol.,
2010
Jul
10
, 637 (138-47).
811
Fabritz L
et al.
Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3.
Cardiovasc. Res.,
2010
Jul
1
, 87 (60-72).
813
Voight BF
et al.
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis.
Nat. Genet.,
2010
Jul
, 42 (579-89).
814
Tester DJ
et al.
Epidemiologic, molecular, and functional evidence suggest A572D-SCN5A should not be considered an independent LQT3-susceptibility mutation.
Heart Rhythm,
2010
Jul
, 7 (912-9).
815
Hayashi K
et al.
Trafficking-competent KCNQ1 variably influences the function of HERG long QT alleles.
Heart Rhythm,
2010
Jul
, 7 (973-80).
816
817
Market-Velker BA
et al.
Dual effects of superovulation: loss of maternal and paternal imprinted methylation in a dose-dependent manner.
Hum. Mol. Genet.,
2010
Jan
1
, 19 (36-51).
818
Ponte ML
et al.
Mechanisms of Drug Induced QT Interval Prolongation.
Curr Drug Saf,
2010
Jan
1
, 5 (44-53).
819
Sung RJ
et al.
Beta-adrenergic modulation of arrhythmogenesis and identification of targeted sites of antiarrhythmic therapy in Timothy (LQT8) syndrome: a theoretical study.
Am. J. Physiol. Heart Circ. Physiol.,
2010
Jan
, 298 (H33-44).
820
Chen Z
et al.
Association study of four variants in KCNQ1 with type 2 diabetes mellitus and premature coronary artery disease in a Chinese population.
Mol. Biol. Rep.,
2010
Jan
, 37 (207-12).
821
Tremblay AM
et al.
Physiological genomics identifies estrogen-related receptor alpha as a regulator of renal sodium and potassium homeostasis and the renin-angiotensin pathway.
Mol. Endocrinol.,
2010
Jan
, 24 (22-32).
822
Shin HD
et al.
Association of KCNQ1 polymorphisms with the gestational diabetes mellitus in Korean women.
J. Clin. Endocrinol. Metab.,
2010
Jan
, 95 (445-9).
823
Lang F
et al.
Heterocyclic indazole derivatives as SGK1 inhibitors, WO2008138448.
Expert Opin Ther Pat,
2010
Jan
, 20 (129-35).
824
Matavel A
et al.
PKA and PKC partially rescue long QT type 1 phenotype by restoring channel-PIP2 interactions.
Channels (Austin),
2010
Jan
, 4 (3-11).
825
Alvarez PA
et al.
QT alterations in psychopharmacology: proven candidates and suspects.
Curr Drug Saf,
2010
Jan
, 5 (97-104).
826
Thomas D
et al.
Biophysical characterization of KCNQ1 P320 mutations linked to long QT syndrome 1.
J. Mol. Cell. Cardiol.,
2010
Jan
, 48 (230-7).
827
Abraham RL
et al.
Augmented potassium current is a shared phenotype for two genetic defects associated with familial atrial fibrillation.
J. Mol. Cell. Cardiol.,
2010
Jan
, 48 (181-90).
828
Charpentier F
et al.
Delayed rectifier K(+) currents and cardiac repolarization.
J. Mol. Cell. Cardiol.,
2010
Jan
, 48 (37-44).
829
Banderali U
et al.
Impaired stretch modulation in potentially lethal cardiac sodium channel mutants.
Channels (Austin),
2010
Jan
, 4 (12-21).
830
Mashanov GI
et al.
Direct observation of individual KCNQ1 potassium channels reveals their distinctive diffusive behavior.
J. Biol. Chem.,
2010
Feb
5
, 285 (3664-75).
831
Massaeli H
et al.
Extracellular K+ Is a Prerequisite for the Function and Plasma Membrane Stability of HERG Channels.
,
2010
Feb
4
, ().
832
Kang C
et al.
Functional delivery of a membrane protein into oocyte membranes using bicelles.
Biochemistry,
2010
Feb
2
, 49 (653-5).
833
Bal M
et al.
Ca2+/calmodulin disrupts AKAP79/150 interactions with KCNQ (M-Type) K+ channels.
J. Neurosci.,
2010
Feb
10
, 30 (2311-23).
834
Saba S
et al.
Effect of right ventricular versus biventricular pacing on electrical remodeling in the normal heart.
Circ Arrhythm Electrophysiol,
2010
Feb
1
, 3 (79-87).
835
Grunnet M
Repolarization of the cardiac action potential. Does an increase in repolarization capacity constitute a new anti-arrhythmic principle?
Acta Physiol (Oxf),
2010
Feb
, 198 Suppl 676 (1-48).
836
Harmer SC
et al.
Mechanisms of disease pathogenesis in long QT syndrome type 5.
Am. J. Physiol., Cell Physiol.,
2010
Feb
, 298 (C263-73).
837
Mansén A
et al.
Thyroid hormone receptor alpha can control action potential duration in mouse ventricular myocytes through the KCNE1 ion channel subunit.
Acta Physiol (Oxf),
2010
Feb
, 198 (133-42).
838
Jing H
et al.
Ephedrine controls heart rhythms by activating cardiac I(ks) currents.
J. Cardiovasc. Pharmacol.,
2010
Feb
, 55 (145-52).
839
Lian J
et al.
[A novel mutation of the KCNH2 gene in a family with congenital long QT syndrome]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi,
2010
Feb
, 27 (77-80).
840
Grallert H
et al.
Association of genetic variation in KCNQ1 with type 2 diabetes in the KORA surveys.
Horm. Metab. Res.,
2010
Feb
, 42 (149-51).
841
Eggermann T
et al.
Identification of a 21q22 duplication in a Silver-Russell syndrome patient further narrows down the Down syndrome critical region.
Am. J. Med. Genet. A,
2010
Feb
, 152A (356-9).
842
Serratrice G
et al.
[Potassium channelopathies and Morvan's syndromes].
Bull. Acad. Natl. Med.,
2010
Feb
, 194 (391-406; discussion 406-7).
843
Osteen JD
et al.
KCNE1 alters the voltage sensor movements necessary to open the KCNQ1 channel gate.
Proc. Natl. Acad. Sci. U.S.A.,
2010
Dec
28
, 107 (22710-5).
844
Wu D
et al.
KCNE1 remodels the voltage sensor of Kv7.1 to modulate channel function.
Biophys. J.,
2010
Dec
1
, 99 (3599-608).
845
Cao X
et al.
Cardiac ion channel safety profiling on the IonWorks Quattro automated patch clamp system.
Assay Drug Dev Technol,
2010
Dec
, 8 (766-80).
846
Schimpf R
et al.
Arrhythmogenic hereditary syndromes: Brugada Syndrome, long QT syndrome, short QT syndrome and CPVT.
Minerva Cardioangiol,
2010
Dec
, 58 (623-36).
847
Soh H
et al.
The specific slow afterhyperpolarization inhibitor UCL2077 is a subtype-selective blocker of the epilepsy associated KCNQ channels.
Mol. Pharmacol.,
2010
Dec
, 78 (1088-95).
848
Kim HT
et al.
Long QT syndrome provoked by induction of general anesthesia -A case report-.
Korean J Anesthesiol,
2010
Dec
, 59 Suppl (S114-8).
849
Blana A
et al.
Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability.
Heart Rhythm,
2010
Dec
, 7 (1862-9).
850
Burashnikov E
et al.
Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death.
Heart Rhythm,
2010
Dec
, 7 (1872-82).
851
Kim JA
et al.
Trigger-specific risk factors and response to therapy in long QT syndrome type 2.
Heart Rhythm,
2010
Dec
, 7 (1797-805).
852
El Harchi A
et al.
The S140G KCNQ1 atrial fibrillation mutation affects 'I(KS)' profile during both atrial and ventricular action potentials.
J. Physiol. Pharmacol.,
2010
Dec
, 61 (759-64).
853
Macías A
et al.
Celecoxib blocks cardiac Kv1.5, Kv4.3 and Kv7.1 (KCNQ1) channels: effects on cardiac action potentials.
J. Mol. Cell. Cardiol.,
2010
Dec
, 49 (984-92).
854
Cordeiro JM
et al.
Overlapping LQT1 and LQT2 phenotype in a patient with long QT syndrome associated with loss-of-function variations in KCNQ1 and KCNH2.
Can. J. Physiol. Pharmacol.,
2010
Dec
, 88 (1181-90).
855
Hori N
et al.
Aberrant CpG methylation of the imprinting control region KvDMR1 detected in assisted reproductive technology-produced calves and pathogenesis of large offspring syndrome.
Anim. Reprod. Sci.,
2010
Dec
, 122 (303-12).
856
Rodriguez N
et al.
Phosphatidylinositol-4,5-Bisphosphate (PIP(2)) Stabilizes the Open Pore Conformation of the Kv11.1 (hERG) Channel.
,
2010
Aug
9
, 99 (1110-1118).
858
Durdagi S
et al.
Insights into the Molecular Mechanism of hERG1 Channel Activation and Blockade by Drugs.
,
2010
Aug
26
, ().
859
Tu E
et al.
Post-Mortem Review and Genetic Analysis of Sudden Unexpected Death in Epilepsy (SUDEP) Cases.
,
2010
Aug
24
, ().
860
Choufani S
et al.
Beckwith-Wiedemann syndrome.
Am J Med Genet C Semin Med Genet,
2010
Aug
15
, 154C (343-54).
861
Weaver JR
et al.
Domain-specific response of imprinted genes to reduced DNMT1.
Mol. Cell. Biol.,
2010
Aug
, 30 (3916-28).
862
Stead LF
et al.
KvDB; mining and mapping sequence variants in voltage-gated potassium channels.
Hum. Mutat.,
2010
Aug
, 31 (908-17).
863
Albert CM
et al.
Common Variants in Cardiac Ion Channel Genes Are Associated with Sudden Cardiac Death.
,
2010
Apr
17
, ().
864
Lee HA
et al.
Electrophysiological Effects of the Anti-Cancer Drug Lapatinib on Cardiac Repolarization.
,
2010
Apr
12
, ().
865
Wong JA
et al.
Utility of treadmill testing in identification and genotype prediction in long-QT syndrome.
Circ Arrhythm Electrophysiol,
2010
Apr
1
, 3 (120-5).
866
Kanovsky J
et al.
A new homozygous mutation of the KCNQ1 gene associated with both Romano-Ward and incomplete Jervell Lange-Nielsen syndromes in two sisters.
Heart Rhythm,
2010
Apr
, 7 (531-3).
867
Nof E
et al.
A common single nucleotide polymorphism can exacerbate long-QT type 2 syndrome leading to sudden infant death.
Circ Cardiovasc Genet,
2010
Apr
, 3 (199-206).
868
El Harchi A
et al.
Action potential clamp and mefloquine sensitivity of recombinant 'I KS' channels incorporating the V307L KCNQ1 mutation.
J. Physiol. Pharmacol.,
2010
Apr
, 61 (123-31).
869
Ohshige T
et al.
A single nucleotide polymorphism in KCNQ1 is associated with susceptibility to diabetic nephropathy in japanese subjects with type 2 diabetes.
Diabetes Care,
2010
Apr
, 33 (842-6).
870
Gladding PA
et al.
Posthumous diagnosis of long QT syndrome from neonatal screening cards.
Heart Rhythm,
2010
Apr
, 7 (481-6).
871
Subbiah RN
et al.
Torsades de pointes during complete atrioventricular block: Genetic factors and electrocardiogram correlates.
Can J Cardiol,
2010
Apr
, 26 (208-12).
872
Oh-McGinnis R
et al.
Rescue of placental phenotype in a mechanistic model of Beckwith-Wiedemann syndrome.
BMC Dev. Biol.,
2010
, 10 (50).
873
Duranton C
et al.
KCNQ1 K+ channels are involved in lipopolysaccharide-induced apoptosis of distal kidney cells.
Cell. Physiol. Biochem.,
2010
, 25 (367-78).
874
Tsai FJ
et al.
A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese.
PLoS Genet.,
2010
, 6 (e1000847).
876
Frost JM
et al.
Telomeric NAP1L4 and OSBPL5 of the KCNQ1 cluster, and the DECORIN gene are not imprinted in human trophoblast stem cells.
PLoS ONE,
2010
, 5 (e11595).
877
Roepke TK
et al.
Targeted deletion of Kcne2 causes gastritis cystica profunda and gastric neoplasia.
PLoS ONE,
2010
, 5 (e11451).
878
Kwak SH
et al.
Polymorphisms in KCNQ1 are associated with gestational diabetes in a Korean population.
Horm Res Paediatr,
2010
, 74 (333-8).
879
Kotta CM
et al.
Cardiac ion channel gene mutations in Greek long QT syndrome patients.
J. Appl. Genet.,
2010
, 51 (515-8).
880
Nakajima T
et al.
Aborted cardiac arrest in a patient carrying KCNE1 D85N variant during the postpartum period.
Intern. Med.,
2010
, 49 (1875-8).
881
Cardona K
et al.
Effects of late sodium current enhancement during LQT-related arrhythmias. A simulation study.
Conf Proc IEEE Eng Med Biol Soc,
2010
, 2010 (3237-40).
882
Chen Z
et al.
KCNQ1 gene polymorphisms are associated with lipid parameters in a Chinese Han population.
Cardiovasc Diabetol,
2010
, 9 (35).
883
Nakajima T
et al.
Post myocardial ischemia-associated torsades de pointes in a patient carrying a KCNQ1 G643S variant.
Intern. Med.,
2010
, 49 (2587-91).
884
Lee HA
et al.
Cellular mechanism of the QT prolongation induced by sulpiride.
Int. J. Toxicol.,
2009 May-Jun
, 28 (207-12).
885
Strutz-Seebohm N
et al.
Serum- and glucocorticoid-inducible kinases (SGK) regulate KCNQ1/KCNE potassium channels.
Channels (Austin),
2009 Mar-Apr
, 3 (88-90).
886
Towart R
et al.
Blockade of the I(Ks) potassium channel: an overlooked cardiovascular liability in drug safety screening?
J Pharmacol Toxicol Methods,
2009 Jul-Aug
, 60 (1-10).
887
Kurokawa J
et al.
KCNE variants reveal a critical role of the beta subunit carboxyl terminus in PKA-dependent regulation of the IKs potassium channel.
Channels (Austin),
2009 Jan-Feb
, 3 (16-24).
888
Qi Q
et al.
Common variants in KCNQ1 are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population.
Hum. Mol. Genet.,
2009
Sep
15
, 18 (3508-15).
889
Rieg T
et al.
Unravelling a role for KCNQ1 in K+ recycling and gastric acid secretion.
J. Physiol. (Lond.),
2009
Sep
1
, 587 (4149-50).
890
Guo J
et al.
Extracellular K+ concentration controls cell surface density of IKr in rabbit hearts and of the HERG channel in human cell lines.
J. Clin. Invest.,
2009
Sep
, 119 (2745-57).
891
Vanoye CG
et al.
Distinct subdomains of the KCNQ1 S6 segment determine channel modulation by different KCNE subunits.
J. Gen. Physiol.,
2009
Sep
, 134 (207-17).
892
Kapplinger JD
et al.
Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.
Heart Rhythm,
2009
Sep
, 6 (1297-303).
893
Overholser BR
et al.
Paroxysmal beta-adrenergic receptor-mediated alterations in ventricular repolarization at rapid heart rates during inhibition of delayed rectifier currents.
J. Cardiovasc. Pharmacol.,
2009
Sep
, 54 (253-62).
895
Heron SE
et al.
Neonatal seizures and Long QT Syndrome: A cardiocerebral channelopathy?
Epilepsia,
2009
Oct
27
, ().
896
Goldman AM
et al.
Arrhythmia in heart and brain: KCNQ1 mutations link epilepsy and sudden unexplained death.
Sci Transl Med,
2009
Oct
14
, 1 (2ra6).
897
Ziv O
et al.
Origin of complex behaviour of spatially discordant alternans in a transgenic rabbit model of type 2 long QT syndrome.
J. Physiol. (Lond.),
2009
Oct
1
, 587 (4661-80).
898
Roepke TK
et al.
Kcne2 deletion uncovers its crucial role in thyroid hormone biosynthesis.
Nat. Med.,
2009
Oct
, 15 (1186-94).
899
Jonsson A
et al.
A variant in the KCNQ1 gene predicts future type 2 diabetes and mediates impaired insulin secretion.
Diabetes,
2009
Oct
, 58 (2409-13).
900
Itoh H
et al.
Latent genetic backgrounds and molecular pathogenesis in drug-induced long-QT syndrome.
Circ Arrhythm Electrophysiol,
2009
Oct
, 2 (511-23).
901
Xu Q
et al.
Crystal structure of a trimeric form of the K(V)7.1 (KCNQ1) A-domain tail coiled-coil reveals structural plasticity and context dependent changes in a putative coiled-coil trimerization motif.
Protein Sci.,
2009
Oct
, 18 (2100-14).
902
Kapa S
et al.
Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants.
Circulation,
2009
Nov
3
, 120 (1752-60).
903
Shimizu W
et al.
Genotype-phenotype aspects of type 2 long QT syndrome.
J. Am. Coll. Cardiol.,
2009
Nov
24
, 54 (2052-62).
904
Padilla K
et al.
The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site.
Neurosci. Lett.,
2009
Nov
13
, 465 (138-42).
905
O'Mahony F
et al.
Novel female sex-dependent actions of oestrogen in the intestine.
J. Physiol. (Lond.),
2009
Nov
1
, 587 (5039-44).
906
Brink PA
et al.
Of founder populations, long QT syndrome, and destiny.
Heart Rhythm,
2009
Nov
, 6 (S25-33).
907
Lang F
et al.
Targeting SGK1 in diabetes.
Expert Opin. Ther. Targets,
2009
Nov
, 13 (1303-11).
908
Hedley PL
et al.
The genetic basis of long QT and short QT syndromes: a mutation update.
Hum. Mutat.,
2009
Nov
, 30 (1486-511).
909
Ogawa K
et al.
Isolated non-compaction of the ventricular myocardium associated with long QT syndrome: a report of 2 cases.
Circ. J.,
2009
Nov
, 73 (2169-72).
910
Zhou Q
et al.
Association of KCNQ1 gene polymorphism with gestational diabetes mellitus in a Chinese population.
Diabetologia,
2009
Nov
, 52 (2466-8).
911
Maguy A
et al.
Ion channel subunit expression changes in cardiac Purkinje fibers: a potential role in conduction abnormalities associated with congestive heart failure.
Circ. Res.,
2009
May
8
, 104 (1113-22).
912
Li W
et al.
The G314S KCNQ1 mutation exerts a dominant-negative effect on expression of KCNQ1 channels in oocytes.
Biochem. Biophys. Res. Commun.,
2009
May
29
, 383 (206-9).
913
Bankston JR
et al.
Molecular determinants of local anesthetic action of beta-blocking drugs: Implications for therapeutic management of long QT syndrome variant 3.
J. Mol. Cell. Cardiol.,
2009
May
28
, ().
914
Hammami S
et al.
Cell volume and membrane stretch independently control K+ channel activity.
J. Physiol. (Lond.),
2009
May
15
, 587 (2225-31).
915
Makita N
Phenotypic overlap of cardiac sodium channelopathies: individual-specific or mutation-specific?
Circ. J.,
2009
May
, 73 (810-7).
916
Nishio H
et al.
Identification of an ethnic-specific variant (V207M) of the KCNQ1 cardiac potassium channel gene in sudden unexplained death and implications from a knock-in mouse model.
Int. J. Legal Med.,
2009
May
, 123 (253-7).
917
Matavel A
et al.
PKC activation and PIP(2) depletion underlie biphasic regulation of IKs by Gq-coupled receptors.
J. Mol. Cell. Cardiol.,
2009
May
, 46 (704-12).
918
Chen J
et al.
PKA phosphorylation of HERG protein regulates the rate of channel synthesis.
Am. J. Physiol. Heart Circ. Physiol.,
2009
May
, 296 (H1244-54).
919
Huang H
et al.
Biophysical characterization of a new SCN5A mutation S1333Y in a SIDS infant linked to long QT syndrome.
FEBS Lett.,
2009
Mar
4
, 583 (890-6).
920
Yeh YH
et al.
Funny current downregulation and sinus node dysfunction associated with atrial tachyarrhythmia: a molecular basis for tachycardia-bradycardia syndrome.
Circulation,
2009
Mar
31
, 119 (1576-85).
921
Tsurugi T
et al.
Differential modulation of late sodium current by protein kinase A in R1623Q mutant of LQT3.
Life Sci.,
2009
Mar
13
, 84 (380-7).
922
McCrossan ZA
et al.
Regulation of the Kv2.1 potassium channel by MinK and MiRP1.
J. Membr. Biol.,
2009
Mar
, 228 (1-14).
923
Salama G
et al.
Arrhythmia phenotype in mouse models of human long QT.
,
2009
Mar
, 24 (77-87).
924
Aurlien D
et al.
New SCN5A mutation in a SUDEP victim with idiopathic epilepsy.
,
2009
Mar
, 18 (158-60).
925
McCallum LA
et al.
Expression and function of K(v)7 channels in murine myometrium throughout oestrous cycle.
Pflugers Arch.,
2009
Mar
, 457 (1111-20).
926
Namkung W
et al.
In situ measurement of airway surface liquid [K+] using a ratioable K+-sensitive fluorescent dye.
J. Biol. Chem.,
2009
Jun
5
, 284 (15916-26).
927
Ureche ON
et al.
Differential modulation of cardiac potassium channels by Grb adaptor proteins.
Biochem. Biophys. Res. Commun.,
2009
Jun
19
, 384 (28-31).
928
Jiang M
et al.
Dynamic partnership between KCNQ1 and KCNE1 and influence on cardiac IKs current amplitude by KCNE2.
J. Biol. Chem.,
2009
Jun
12
, 284 (16452-62).
929
Ahrens-Nicklas RC
et al.
Re-evaluating the efficacy of beta-adrenergic agonists and antagonists in long QT-3 syndrome through computational modelling.
Cardiovasc. Res.,
2009
Jun
1
, 82 (439-47).
930
Hardman RM
et al.
Ether-à-go-go-related gene K+ channels contribute to threshold excitability of mouse auditory brainstem neurons.
J. Physiol. (Lond.),
2009
Jun
1
, 587 (2487-97).
931
Xu X
et al.
MinK-dependent internalization of the IKs potassium channel.
Cardiovasc. Res.,
2009
Jun
1
, 82 (430-8).
932
Schimpf R
et al.
Channelopathies: Brugada syndrome, long QT syndrome, short QT syndrome, and CPVT.
,
2009
Jun
, 34 (281-8).
933
Zienciuk A
et al.
[Atrial fibrillation in the long QT syndrome]
Kardiol Pol,
2009
Jun
, 67 (681-4, discussion 685-6).
934
Bush WS
et al.
Genetic variation in the rhythmonome: ethnic variation and haplotype structure in candidate genes for arrhythmias.
Pharmacogenomics,
2009
Jun
, 10 (1043-53).
935
Tan JT
et al.
Genetic variation in KCNQ1 associates with fasting glucose and beta-cell function: a study of 3,734 subjects comprising three ethnicities living in Singapore.
Diabetes,
2009
Jun
, 58 (1445-9).
936
Boini KM
et al.
Enhanced insulin sensitivity of gene-targeted mice lacking functional KCNQ1.
Am. J. Physiol. Regul. Integr. Comp. Physiol.,
2009
Jun
, 296 (R1695-701).
937
Sun Y
et al.
A novel nonsense mutation Y652X in the S6/pore region of human ether-go-go gene found in a long QT syndrome family.
Scand. Cardiovasc. J.,
2009
Jun
, 43 (181-6).
938
Silva JR
et al.
A multiscale model linking ion-channel molecular dynamics and electrostatics to the cardiac action potential.
Proc. Natl. Acad. Sci. U.S.A.,
2009
Jul
7
, 106 (11102-6).
939
Haitin Y
et al.
Intracellular domains interactions and gated motions of I(KS) potassium channel subunits.
EMBO J.,
2009
Jul
22
, 28 (1994-2005).
940
Bajwa PJ
et al.
Activation of PPARgamma by rosiglitazone attenuates intestinal Cl- secretion.
Am. J. Physiol. Gastrointest. Liver Physiol.,
2009
Jul
, 297 (G82-9).
941
Hu C
et al.
Variations in KCNQ1 are associated with type 2 diabetes and beta cell function in a Chinese population.
Diabetologia,
2009
Jul
, 52 (1322-5).
942
Zankov DP
et al.
Adrenergic regulation of the rapid component of delayed rectifier K+ current: implications for arrhythmogenesis in LQT2 patients.
Heart Rhythm,
2009
Jul
, 6 (1038-46).
943
Takeuchi F
et al.
Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population.
Diabetes,
2009
Jul
, 58 (1690-9).
944
Müssig K
et al.
Association of type 2 diabetes candidate polymorphisms in KCNQ1 with incretin and insulin secretion.
Diabetes,
2009
Jul
, 58 (1715-20).
945
Pawelczyk M
et al.
Analysis of gene polymorphisms associated with K ion circulation in the inner ear of patients susceptible and resistant to noise-induced hearing loss.
Ann. Hum. Genet.,
2009
Jul
, 73 (411-21).
946
Missan S
et al.
Regulation of wild-type and mutant KCNQ1/KCNE1 channels by tyrosine kinase.
Pflugers Arch.,
2009
Jul
, 458 (471-80).
947
El-Sherif N
et al.
Role of pharmacotherapy in cardiac ion channelopathies.
,
2009
Jul
, 7 (358-66).
948
Dautova Y
et al.
Atrial arrhythmogenesis in wild-type and Scn5a+/delta murine hearts modelling LQT3 syndrome.
Pflugers Arch.,
2009
Jul
, 458 (443-57).
949
Ackerman MJ
State of postmortem genetic testing known as the cardiac channel molecular autopsy in the forensic evaluation of unexplained sudden cardiac death in the young.
Pacing Clin Electrophysiol,
2009
Jul
, 32 Suppl 2 (S86-9).
950
Liu Y
et al.
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes in the population of mainland China.
Diabetologia,
2009
Jul
, 52 (1315-21).
951
Yang T
et al.
Probing the mechanisms underlying modulation of quinidine sensitivity to cardiac I(Ks) block by protein kinase A-mediated I(Ks) phosphorylation.
Br. J. Pharmacol.,
2009
Jul
, 157 (952-61).
952
Zamorano-León JJ
et al.
Novel mutation (H402R) in the S1 domain of KCNH2-encoded gene associated with long QT syndrome in a Spanish family.
Int. J. Cardiol.,
2009
Jan
9
, ().
953
Delisle BP
et al.
Small GTPase determinants for the Golgi processing and plasmalemmal expression of human ether-a-go-go related (hERG) K+ channels.
J. Biol. Chem.,
2009
Jan
30
, 284 (2844-53).
954
Chung DY
et al.
Location of KCNE1 relative to KCNQ1 in the I(KS) potassium channel by disulfide cross-linking of substituted cysteines.
Proc. Natl. Acad. Sci. U.S.A.,
2009
Jan
20
, 106 (743-8).
955
Wang H
et al.
Expression of the voltage-gated potassium channel KCNQ1 in mammalian taste bud cells and the effect of its null-mutation on taste preferences.
J. Comp. Neurol.,
2009
Jan
20
, 512 (384-98).
956
Johnson JN
et al.
Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy.
Neurology,
2009
Jan
20
, 72 (224-31).
957
Ikrar T
et al.
Evaluation of channel function after alteration of amino acid residues at the pore center of KCNQ1 channel.
Biochem. Biophys. Res. Commun.,
2009
Jan
16
, 378 (589-94).
958
Manderfield LJ
et al.
KCNE4 domains required for inhibition of KCNQ1.
J. Physiol. (Lond.),
2009
Jan
15
, 587 (303-14).
959
Barajas-Martinez H
et al.
Larger dispersion of INa in female dog ventricle as a mechanism for gender-specific incidence of cardiac arrhythmias.
Cardiovasc. Res.,
2009
Jan
1
, 81 (82-9).
960
Shin JM
et al.
The gastric HK-ATPase: structure, function, and inhibition.
Pflugers Arch.,
2009
Jan
, 457 (609-22).
961
Lehtinen AB
et al.
Relationship between genetic variants in myocardial sodium and potassium channel genes and QT interval duration in diabetics: the Diabetes Heart Study.
Ann Noninvasive Electrocardiol,
2009
Jan
, 14 (72-9).
962
Markiewicz-Łoskot G
et al.
The risk of cardiac events and genotype-based management of LQTS patients.
Ann Noninvasive Electrocardiol,
2009
Jan
, 14 (86-92).
966
Diness JG
et al.
Antiarrhythmic effect of IKr activation in a cellular model of LQT3.
Heart Rhythm,
2009
Jan
, 6 (100-6).
967
Kauferstein S
et al.
Cardiac gene defects can cause sudden cardiac death in young people.
Dtsch Arztebl Int,
2009
Jan
, 106 (41-7).
968
Kanber D
et al.
Low frequency of imprinting defects in ICSI children born small for gestational age.
Eur. J. Hum. Genet.,
2009
Jan
, 17 (22-9).
969
Asada K
et al.
Redox- and calmodulin-dependent S-nitrosylation of the KCNQ1 channel.
J. Biol. Chem.,
2009
Feb
27
, 284 (6014-20).
970
Li W
et al.
Congenital long QT syndrome caused by the F275S KCNQ1 mutation: mechanism of impaired channel function.
Biochem. Biophys. Res. Commun.,
2009
Feb
27
, 380 (127-31).
971
Peroz D
et al.
LQT1-associated mutations increase KCNQ1 proteasomal degradation independently of Derlin-1.
J. Biol. Chem.,
2009
Feb
20
, 284 (5250-6).
972
Yang HT
et al.
HERG -F463L Potassium Channels Linked to Long QT Syndrome Reduce I Current by a Trafficking-Deficient Mechanism.
Clin. Exp. Pharmacol. Physiol.,
2009
Feb
10
, ().
973
Bardou O
et al.
Molecular diversity and function of K+ channels in airway and alveolar epithelial cells.
Am. J. Physiol. Lung Cell Mol. Physiol.,
2009
Feb
, 296 (L145-55).
974
Bruce S
et al.
Clinically distinct epigenetic subgroups in Silver-Russell syndrome: the degree of H19 hypomethylation associates with phenotype severity and genital and skeletal anomalies.
J. Clin. Endocrinol. Metab.,
2009
Feb
, 94 (579-87).
975
Ma L
et al.
[The effects of hypokalemia on the Na+ channel in cardiac tissue--a computer simulation study]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi,
2009
Feb
, 26 (1-5).
976
Potet F
et al.
Genetic screening in C. elegans identifies rho-GTPase activating protein 6 as novel HERG regulator.
J. Mol. Cell. Cardiol.,
2009
Feb
, 46 (257-67).
977
Pan N
et al.
A hydrophobicity-dependent motif responsible for surface expression of cardiac potassium channel.
Cell. Signal.,
2009
Feb
, 21 (349-55).
978
Greenwood IA
et al.
KCNQ-encoded channels regulate Na+ transport across H441 lung epithelial cells.
Pflugers Arch.,
2009
Feb
, 457 (785-94).
979
Crotti L
et al.
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome.
Heart Rhythm,
2009
Feb
, 6 (212-8).
980
Choi E
et al.
A shared mechanism for lipid- and {beta}-subunit-coordinated stabilization of the activated K+ channel voltage sensor.
,
2009
Dec
29
, ().
981
Lundby A
et al.
Structural basis for KV7.1/KCNEx interactions in the IKs channel complex.
,
2009
Dec
24
, ().
982
Sato A
et al.
Novel mechanisms of trafficking defect caused by KCNQ1 mutations found in long QT syndrome.
J. Biol. Chem.,
2009
Dec
11
, 284 (35122-33).
983
984
Winbo A
et al.
Low incidence of sudden cardiac death in a Swedish Y111C type 1 long-QT syndrome population.
Circ Cardiovasc Genet,
2009
Dec
, 2 (558-64).
985
Shi RM
et al.
[Gene mutation analysis of a Chinese family of congenital long Q-T syndrome type three.]
Zhonghua Er Ke Za Zhi,
2009
Dec
, 47 (926-30).
986
Iturralde-Torres P
et al.
[Genetic in long QT syndromes]
Arch Cardiol Mex,
2009
Dec
, 79 Suppl 2 (26-30).